Immunovia Half-year report 2016

“Immunovia reached several important milestones in the first six months of 2016. Good results were obtained in the American pancreas study that was carried out in collabo­ration with Knight Cancer Institute. Presentations made at the key global conferences concerning pancreatic cancer were very well received. A specially strong Scientific Advisory Board has been recruited, and involvement from the patient organization has increased. Furthermore, several significant agreements were signed with important cancer centres. The market introduction of IMMray™ PanCan –d, Immunovia’s diagnosis test for early detection of pancreatic cancer, is expected to begin in 2017 and then generate income from the hereditary risk groups in 2018. It is planned to start pancreatic cancer tests for the diabetes group soon afterwards. In addition, it will be possible to use the test for patients seeking help with vague symptoms and where there is a need to swiftly rule out pancreatic cancer. In the second half of 2016 Immunovia’s laboratory in Lund is expected to be completed and subsequently accredited for ISO certification in 2017. CE labelling of IMMray™ PanCan –d will be concluded in 2017. It will then be possible to receive samples from all over Europe to establish early detection of pancreatic cancer, with talks already being held with several prospective customers, i.e. cancer centres and laboratories. In mid-August Immunovia announced its intention to seek a listing on Nasdaq Stockholm’s Main Market in 2017.” Key Indicators +----------------------+-----------------+-----------------+-------------+|Key   Indicators  |1 Jan-30 Jun 2016|1 Jan-30 Jun 2015| 2015 ||(SEK 000 unless | | | Full year ||otherwise stated) | | | |+----------------------+-----------------+-----------------+-------------+|Net   sales | 66| 59| 205|+----------------------+-----------------+-----------------+-------------+|Operating   earnings | -5 403| -3 836| -7 424|+----------------------+-----------------+-----------------+-------------+|Earnings   before tax | -5 298| -3 807| -7 384|+----------------------+-----------------+-----------------+-------------+|Net earnings | -5 298| -3 807| -7 384|+----------------------+-----------------+-----------------+-------------+|Earnings   per share | -0,38| -0,34| -0,65||before dilution | | | ||(SEK/share) | | | |+----------------------+-----------------+-----------------+-------------+|Earnings   per share | -0,36| -0,33| -0,62||after dilution | | | ||(SEK/share) | | | |+----------------------+-----------------+-----------------+-------------+| | | | |+----------------------+-----------------+-----------------+-------------+| | 30 Jun 2016  | 30 Jun 2015  |31   Dec 2015|+----------------------+-----------------+-----------------+-------------+|Equity   ratio, % | 93| 84| 92|+----------------------+-----------------+-----------------+-------------+|Gearing   ratio, times| 0,07| 0,19| 0,09|+----------------------+-----------------+-----------------+-------------+ Outlook*Immunovia is focused on fundamentally transforming diagnosis of complex forms of cancer and autoimmune diseases. The antibody-based platform, IMMrayTM, is the result of 15 years of research at CREATE Health – the Center for Translational Cancer Research at Lund University, Sweden. IMMray™ is a technology platform for the development of diagnostic tests and the company’s primary test, IMMray™ PanCan-d, is the first test in the world for early diagnosis of pancreatic cancer. ·  It is planned to launch IMMray™ PanCan-d on the American and European markets with sales start in 2017 to out-of-pocket customers, with revenues expected to begin in 2018. In coming years Immunovia will address a market that in total is worth around SEK 30 billion. ·  Immunovia sees great potential in the development of tests for other unsolved problems in cancer and autoimmune diseases via its IMMray™ platform. The next focus area will be tests within SLE. *No changes compared with the Financial Statement dated 24 February 2016. For further information, please contact:Mats Grahn, CEO, Immunovia ABPhone: +46 (0) 70-532 02 30E-mail: mats.grahn@immunovia.com  About ImmunoviaImmunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray™ PanCan-d that could be the first blood based test for early diagnosis of pancreatic cancer.  In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. The first test from this program, IMMray™ SLE-d, is a biomarker signature derived for differential diagnosis of lupus, now undergoing evaluation and validation. (Source: www.immunovia.com)  Immunovia’s shares (IMMNOV) are listed on Nasdaq First North in Stockholm and Wildeco is the company’s Certified Adviser. For more information, please visit www.immunovia.com. ###

Nanologica enters into research collaboration with GSK

”We are excited about the collaboration with GSK. This is an early, but interesting project with the possibility to unlock new approaches to personalized medicine. It is a great opportunity for Nanologica to contribute to this field,” says Nanologica’s CEO Andreas Bhagwani. This paid development project is in line with Nanologica’s strategy in the business area Drug Delivery. The business model in Drug Delivery is based on having many different projects in collaboration with pharmaceutical companies to apply Nanologica’s proprietary technology to real problems of drug developers. Nanologica is increasingly seeking projects where potentially more value can be created, as this agreement illustrates. “The healthcare industry is showing growing interest in Nanologica’s technology, which for us is good evidence that we are on the right track. Our goal is to be the world-wide expert in porous silica-based materials for life science applications,” says Andreas Bhagwani. Early projects can be the starting point of long-term collaborations, but can also be limited to the initial scope and timeline. Nanologica is constantly evaluating new project proposals with the goal to identify opportunities to apply and commercialize its drug delivery systems. For further information, please contact: Andreas Bhagwani, CEO of Nanologica phone: +46 70 316 17 02 or e-mail: andreas@nanologica.com About Nanologica Nanologica develops nanoporous silica for applications in life science. The company focuses on two business areas: drug delivery and chromatography, a technology used for the separation and purification of products on the market and in development. Nanologica’s core competency is to apply its unique know-how in the field of material science for developing nanoporous silica particles with unique characteristics. Based in Södertälje, Sweden, Nanologica has 19 employees from ten nationalities of which ten are PhDs. For more information, please visit www.nanologica.com.

NeuroVive’s Chief Operating Officer Jan Nilsson leaves the company

The company is entering into a very important period and is expecting exciting developments during the fall. Over the past several months, the business strategy and organization have been re-oriented to optimize the way forward. As one consequence the position of COO is no longer required. “I have been involved in NeuroVive in different roles since 2010 and it has been fantastic to be part of the development of the company to the position it holds today. The company has a very interesting project portfolio and a strong organization. The transition to our new CEO is now concluded which makes the timing right for me to seek new challenges. I will of course follow the company’s continued development with greatest interest”, says Jan Nilsson. “Jan Nilsson has with great dedication, in combination with his vast knowledge and experience, played a key role in NeuroVive, not only as COO but also as a Director and for a period as interim CEO. Jan has been instrumental in managing the challenges faced by NeuroVive in recent years. On behalf of the entire company and its shareholders, I express our respect and appreciation for Jan and wish him all the best in his new endeavors”, says Greg Batcheller, Chairman of NeuroVive. About NeuroVive NeuroVive Pharmaceutical AB (publ) is a pioneer in mitochondrial medicine and a company committed to the discovery and development of highly targeted candidates that preserve mitochondrial integrity and function in areas of significant therapeutic need. NeuroVive's business approach is driven by value-adding partnerships with mitochondrial research institutions and commercial partners across the globe. NeuroVive's portfolio consists of two clinical projects, one in acute kidney injury (CicloMulsion®) and one in traumatic brain injury (NeuroSTAT®). The candidate drug NeuroSTAT has orphan drug designation in Europe and in the US for treatment of moderate to severe traumatic brain injury and is currently being evaluated in the CHIC study. CicloMulsion is being evaluated in an on-going study, CiPRICS, in acute kidney injury during major surgery. Furthermore, the R&D portfolio consists of two late stage discovery programs and one compound in preclinical development. NeuroVive is listed on Nasdaq Stockholm, Sweden, Small Cap, under the ticker symbol NVP. The share is also traded on the OTC Markets Group Inc market in the US. NeuroVive Pharmaceutical (OTC: NEVPF) trades on the OTCQX Best Market. For investor relations and media questions, please contact:  Cecilia Hofvander, NeuroVive, Tel: +46 (0)46 275 62 21 or ir@neurovive.com  NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard), Fax: +46 (0)46 888 83 48www.neurovive.com   This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. CEST on August 24, 2016.  

Cantargia interim report January – June 2016

Significant events in the second quarter  · The exercise period for warrants of series TO 1 and TO 3 began on 23 March 2016 and ended on 13 April 2016. In total, 4,127,260 warrants of both series were exercised, representing around 83.5 per cent of the number of warrants issued. Through the warrants Cantargia raised approximately SEK 31.4 million before issue costs.  · During the period the Company gave investor presentations at the international BioEquity conference in Copenhagen on 10 May 2016 and at the Småbolagsdagen small cap investor event at the Sheraton Stockholm Hotel on 13 June 2016.  · The annual report for the financial year 2015 was published on 29 April 2016. The company held its Annual General Meeting on 25 May 2016 and published a report on the AGM the following day. The annual report and AGM report are available for download on the company’s website, www.cantargia.com.  · Cantargia received a Notice of Allowance from the US Patent Office for IL1RAP as target molecule for antibody-based treatment in acute lymphoblastic leukemia followed by a Notice of Allowance for IL1RAP as target molecule for antibody-based treatment in solid tumours from the same patent office. The company also received formal approval in Japan of a patent for solid tumours.  · The company announced that its CAN04 product candidate has been shown to have a high level safety in high doses – repeated treatment with up to 100 mg/kg. During the period Cantargia also decided that the company will conduct further process development studies to establish a strong foundation for long-term production and that the start of the GLP toxicity study will therefore be postponed until autumn 2016. Consequently, the start of clinical studies will also be postponed until the end of the first quarter of 2017.  · A third party filed an opposition to Cantargia’s patent in Europe for IL1RAP as a target molecule for antibody treatment and leukemia diagnostics. Cantargia will be working with its patent agents and the European Patent Office to conduct the process in a professional and correct manner. Significant events after the end of the period  · In July Cantargia announced that the US Patent Office had approved the company’s application for IL1RAP as target molecule for antibody-based treatment of solid tumours. · In August Cantargia announced that the company’s former CEO, Agneta Svedberg, has exercised 1,250 warrants of series 2011/2016. The exercise of the warrants will raise SEK 250,212.50 for Cantargia. Financial information First half (1 Jan 2016 – 30 Jun 2016)  · Other operating revenue was kSEK 0 (0).  · Earnings after financial items were kSEK -16,023 (-9,059).  · Earnings per share were approximately SEK -0.91 (-0.68).  · The equity/assets ratio was around 87 (89) per cent compared with the beginning of the year.  Second quarter (1 Apr 2016 – 30 Jun 2016) · Other operating revenue was kSEK 0 (0).  · Earnings after financial items were kSEK -7,926 (-5,432).  · Earnings per share were approximately SEK -0.45 (-0.41).  Definitions  · Earnings per share: Profit for the period divided by 17,633,134 shares as at 30 June 2016. · Equity/assets ratio: Equity divided by total capital.  · Unless otherwise indicated, figures in parentheses refer the same period in the previous year.  For further information, please contact Göran Forsberg, CEOTelephone: +46 (0)46 275 62 60E-mail: goran.forsberg@cantargia.comCertified Adviser: Sedermera Fondkommission  This constitutes information that Cantargia is required to publish under the EU’s Market Abuse Regulation. The information was submitted for publication through the above contact person at 8:30 (CEST) on August 24, 2016. 

HiQ ACQUIRES GREAT APES IN FINLAND – BOOSTING THE POSITION WITHIN DESIGN & DIGITAL

“This acquisition will make HiQ’s position even stronger and more relevant – it’s a great enhancement to our existing team of experts within the digital area. This will enable us to move even faster when solving our client’s challenges, all the way from idea to realisation and within the entire chain of people, technology, and business,” says Lars Stugemo, President and CEO of HiQ. Great Apes has a lot in common with HiQ and isn’t afraid to challenge existing ways of doing things. Some of the clients are Linnanmäki, Microsoft, Lidl, Amer Sports, Royal Ravintolat, Paulig Group, the Finnish Defence Forces, and Veikkaus. Great Apes is also one of the most internationally awarded digital agencies in Finland, with repeated recognition from industry-leading competitions such as The Webby Awards, Red Dot Design Awards, and Eurobest, as well as Nordic awards such as Grand One and Grafia’s Best of the Year.  “We are happy to join forces with HiQ. This will give us a lot more body and we look forward to being able to work with larger, more advanced, and game-changing projects,” says Mikko Sairio, partner and one of the three founders of Great Apes.  “I’m happy to welcome Great Apes into the HiQ team. Both HiQ and Great Apes have a strong customer base, and together we can take on even bigger assignments, using technology to create a better and more joyful world. Great Apes is a great match both competence- and culture wise. They share HiQ’s values and are a group of great people; result oriented and with a positive energy,” Stugemo concludes. In relation to the closing on 31 August, 257 832 HiQ shares will be issued, corresponding to a dilution of 0,5 %. Great Apes is expected to make a positive contribution to HiQ’s profit right from the start, and also to its earnings per share. For more information, please contact: Lars Stugemo, President and CEO of HiQ. Tel. +46 8 588 90 000 Jenny Normark Sperens, Head of Corporate Communications. Tel. +46 734 431 007

Leading construction company Sanken Overseas Pvt Ltd selects IFS Applications 9

The company chose IFS Applications to ensure access to improved management information, project profitability information, enhanced stock and employee management as well as management of subcontracting work. The IFS solution purchased by Sanken Overseas (Pvt) Ltd includes finance, supply chain, project management, and human resource capabilities and will be used by 233 employees across the organization’s geographically dispersed operations in Sri Lanka, Maldives, Seychelles, Kenya, Uganda, and Myanmar.  “Sanken is pleased to work with IFS and we look forward to deploying a fully-fledged ERP suite.” said Mr. B. B. Kulupana, Managing Director/CEO of Sanken Overseas (Pvt) Ltd. “Rapid growth of our overseas business has brought on many management challenges, which we hope the IFS solution will help us overcome and transform into an opportunity that can have a positive bearing on our margins and profitability.” Mr. Jayantha De Silva, President/ CEO of IFS Sri Lanka added, “IFS has a proven track record in the construction industry globally and we are happy to be able to embark on yet another construction implementation, this time together with a Sri Lankan company. IFS Applications is a user-friendly and easily adaptable ERP suite that I am sure will be well received by Sanken’s user base. Our experienced team of consultants and I look forward to completing yet another successful implementation.”

Nel ASA: Launches new containerised, turn-key electrolysers

(Oslo, 24 August 2016) Nel Hydrogen Electrolyser, a division of Nel ASA (Nel), today launches the new containerised NEL C-range electrolysers, thereby offering a low-cost, turn-key solution, representing the world’s smallest footprint for containerized, high capacity electrolysers. “It is with great pleasure that we announce the addition of containerised, turn-key solutions to our NEL A-range electrolysers. The existing NEL A-range are already recognised as the benchmark in energy efficiency. The containerised configuration brings a new level of innovative turn-key design, combined with unparalleled efficiency, practical design that enables quick and simple installation and the most compact solution offered in the market today”, says Jon Andre Løkke, CEO of Nel. The new configurations – Nel C-150 and Nel C-300 – are containerised and will be offered in addition to the existing industrial NEL A-range of electrolysers. The new products will have an output capacity of either 150 and 300 Nm3/hr respectively, which is equivalent to about 330 or 660 Kg/day. The standard gas output pressure will be 200 bar, which makes these products ideal for producing renewable hydrogen integrated with hydrogen fueling stations for cars, busses or other utility vehicles. “With these new products, the customer only need to push a button after connecting electricity and water. The new low-cost, turn-key solutions offer everything of our existing NEL A technology, with its proven reliability and robustness, but with added flexibility and ease-of-use. This is hydrogen production technology second to none,” says Løkke. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 90 74 49 49 Bjørn Simonsen, VP Market Development and Public Relations, + 47 97 17 98 21 About Nel Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today. www.nel-hydrogen.com.

NetEnt unveils hidden world of wonder with Secrets of Atlantis launch

Its subaquatic design delights include vibrant sea creatures and an alluring mermaid, on a 5-reel, 4-row, 40-line video slot platform perfected to entice players into its awe-inspiring world. Highlights, nudge wilds, colossal symbol re-spins and win both way features all add to the wondrous NetEnt graphics and ensure players an exciting gaming experience. Simon Hammon, Chief Product Officer of NetEnt, comments: “NetEnt delivers innovative game themes designed to attract players and keep them coming back for more. Now they’ll be able to get submerged in this stunning slot which once again shows why NetEnt is at the head of the market when it comes to casino games.”  View game demo (https://youtu.be/9IiPPMZFOfk) For additional information please contact:Simon Hammon, Chief Product Officer NetEnt, Phone +356 2276 8145simon.hammon@netent.comMarianne Eklund, PR Manager NetEnt, Phone +46 760 024 808marianne.eklund@netent.com  About NetEnt  NetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by their cutting-edge platform. With innovation at its core, NetEnt is committed to helping customers stay ahead of the competition. NetEnt is listed on Nasdaq Stockholm (NET-B), employs 750 people and has offices in Stockholm, Malta, Kiev, Gothenburg, New Jersey, Krakow and Gibraltar. www.netent.com 

Strong performance and profitable growth for Rovio in first half of 2016

Rovio Entertainment has grown profitably in the first half of 2016, even before the profits from the blockbuster Angry Birds Movie have hit the books. The company earned 76,4 mEUR in revenue in the first half, a 10,3 mEUR year-on-year improvement, finishing the first half with an EBIT result of 5,7 mEUR, a 15,9 mEUR improvement over the same period last year. Rovio’s games business is thriving with year-on-year revenue growth of 24 per cent. Rovio’s animation business saw the globally successful theatrical release of The Angry Birds Movie, which opened in the No. 1 position in 52 countries, including the massive Chinese and U.S. markets. The Angry Birds Movie has so far grossed more than 347 million dollars at the box office globally. The movie will open in Japan October 1. “With the excellent performance of our games portfolio and the fantastic movie, the Angry Birds brand is flying high and we are seeing positive EBIT and cash flow development, while fulfilling our mission to create world class entertainment,” says CEO Kati Levoranta. “We currently have several exciting new games and other projects in development, including new IP, and we have started planning the sequel to The Angry Birds Movie.” The Angry Birds Movie was released digitally in selected Asian markets and North America on July 29, where it quickly went to No. 1 on iTunes, followed by DVD and Blu-ray releases on August 16. The in-home release of the film in other countries and territories continues to roll out in the weeks ahead, with most of Europe seeing the in-home release in September.

A new office building rising by Kasarmitori square during the autumn

The ceremonial masonry stone was laid today. The new building will replace the previous City of Helsinki Public Works Department by Kasarmitori square. “The revitalisation of Kaartinkaupunki is one of the major focuses for Helsinki city planning due to its central location, historical surroundings and tourist routes. We are very pleased that the new high quality office building has been designed to sit naturally together with other prime properties on the square”, says Pekka Sauri, Deputy Mayor for Public Works and Environmental Affairs in Helsinki, in his ceremony speech today. While building amongst houses from different eras in the busy city centre both architectural and construction specific technical solutions have to be adopted in the planning and development of the building. “In order to find viable solutions we have needed experienced developers, competent builders and most of all, seamless co-operation to reach our goal”, states YIT ‘s CEO Kari Kauniskangas. The newbuild project has proceeded as planned, the demolition was completed during the summer and the blasting and groundworks have commenced according to schedule, the blasting to be completed already in August-September. “After the cornerstone is set in the construction, we will start with the basements. The excavation will be 10 metres deep and will consist of two basement floors. The lower basement will consist of a ventilation plant room and a service space, and the other one will be a parking hall”, says Tero Ahonen, YIT´s General Foreman. “The frame of this office building will be erected in October and the first floor will be seen from the edge of Kasarmitori in November.  The floors will be completed at the pace of one floor per month. In January 2017 we will start installing the façade in natural stone and installing the first floor windows, which means that the façade is a couple of floors behind the completion of the frame”, continues Ahonen. “All seven floors of the new building will be completed in April and the first tenant is moving in at the end of 2017.” “The deviant traffic arrangements by the Kasarmitori surroundings remain until the very end of this project. They have functioned smoothly so far”, states Ahonen. The project will employ 40-50 YIT employees and a large number of contractors and consultants. The project impact on employment is estimated at up to 400 person-years. Project Info:  Ahlström Capital, YIT and HGR Property Partners are building a new property by Kasarmitori square in Helsinki CBD. The property will provide business space for up to a thousand employees at the end of 2017. The new building will be completed in the city to replace the former City of Helsinki Public Works Department property and it was designed by architects SARC with Antti-Matti Siikala as chief designer. The anchor tenant is Roschier, Attorneys Ltd whose approximately 200 employees will move into the new building as soon as it is ready. The development is located across two different building sites. Roschier has its own entrance into the corner of Kasarmikatu and Pohjoinen Makasiinikatu. The property is built according to the requirements of LEED Platinum certification for green buildings. Contact Information YIT Corporation, Hanna Malmivaara, Vice president, Communications, hanna.malmivaara@yit.fi / +358 40 561 6568 YIT Construction Ltd, Timo Lehmus, timo.lehmus@yit.fi / +358 400 409 181 Ahlström Capital, Hans Sohlström, hans.sohlstrom@ahlstromcapital.com/ +358 10 888 4211 HGR Property Partners, Kari Helin, kari.helin@hgrpp.fi / +358 40 579 0570 Image and other background inquiries HGR Property Partners, Riitta Heikkuri, riitta.heikkuri@hgrpp.fi / +358 40 521 5179 www.kasarmikatu21.fi You can follow the development of the property on social media: Facebook.com/kasarmikatu21 Instagram: @Kasarmikatu21 #Kasarmikatu21 YIT creates sustainable cities and better living environment by developing and constructing housing, business premises, infrastructure and entire areas. We focus on providing a first-class customer experience, high quality and continuous development of our diverse expertise. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2015, our revenue amounted to nearly EUR 1.7 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com  

ASSA ABLOY on Forbes’ list of the world’s 100 most innovative companies

ASSA ABLOY, the global leader in door opening solutions, has for the third time been ranked in Forbes’ list of the world’s most innovative companies 2016. “I’m very pleased that we have achieved such success with our R&D,” says Johan Molin, President and CEO of ASSA ABLOY. "Over the past ten years ASSA ABLOY has invested heavily in innovation, with the goal of doubling the innovation rate and the target that products launched within the past three years should account for at least 25 percent of sales. Today this target has been achieved, with a share of 31 percent of our sales from new products”. ASSA ABLOYs R&D investments have increased by 230 percent since 2005, and today the Group has more than 1 800 development engineers. ASSA ABLOYs ambition is to be the industry’s most innovative company. The full list is available at: http://www.forbes.com/innovative-companies/list/  For more information, please contact:Johan Molin, President and CEO, tel. no: +46 8 506 485 42Carolina Dybeck Happe, CFO and Executive Vice President, tel. no: +46 8 506 485 72 About ASSA ABLOYASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end‑user needs for security, safety and convenience. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with about 46,000 employees, operations in more than 70 countries and sales of SEK 68 billion. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, entrance automation and hotel security.

Notices regarding Handelsbanken’s shares  in Industrivärden

Svenska Handelsbanken (publ) holds 29,367,821 Class A shares in AB Industrivärden (publ), corresponding to 6.8 per cent of Industrivärden’s share capital and 10.3 per cent of the voting rights in Industrivärden. Handelsbanken has decided to offer all such shares to institutional investors through an accelerated bookbuilding (the “Transaction”). Morgan Stanley and Handelsbanken Capital Markets are acting as Joint Bookrunners in connection with the Transaction. For further information, please contact: Ulf Riese, Chief Financial Officer, + 46 8 – 22 92 20Johan Lagerström, Global Head of Corporate Communications, + 46 8 – 701 10 00, + 46 70 – 265 80 14Mikael Hallåker, Head of Investor Relations, + 46 8 –701 29 95, + 46 70 – 266 29 95 This information is of the type that Handelsbanken is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication through the agency of the contact person set out above, on 24 August 2016 at 17.45 CET. For more information about Handelsbanken, see: www.handelsbanken.com (http://www.handelsbanken.se/)  IMPORTANT NOTICE THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL, OR SOLICITATION OF AN OFFER TO BUY, ANY SECURITIES IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") AND MAY NOT BE SOLD IN THE UNITED STATES ABSENT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE WILL NOT BE A PUBLIC OFFERING OF THE SHARES IN THE UNITED STATES. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES OR INVESTMENTS FOR SALE OR A SOLICITATION OF AN OFFER TO BUY SECURITIES OR INVESTMENTS IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION  WOULD BE UNLAWFUL. NO ACTION HAS BEEN TAKEN THAT WOULD PERMIT AN OFFERING OF THE SECURITIES OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUIRED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY SUCH RESTRICTIONS. ANY FAILURE TO COMPLY WITH  THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF ANY SUCH JURISDICTION. IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA ("EEA") WHICH HAVE IMPLEMENTED THE PROSPECTUS DIRECTIVE (EACH, A "RELEVANT MEMBER STATE"), THIS ANNOUNCEMENT AND ANY OFFER IF MADE SUBSEQUENTLY IS DIRECTED EXCLUSIVELY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF THE PROSPECTUS DIRECTIVE ("QUALIFIED INVESTORS"). FOR THESE PURPOSES, THE EXPRESSION "PROSPECTUS DIRECTIVE" MEANS DIRECTIVE 2003/71/EC (AND AMENDMENTS THERETO, INCLUDING THE 2010 PD AMENDING DIRECTIVE, TO THE EXTENT IMPLEMENTED IN A RELEVANT MEMBER STATE), AND INCLUDES ANY RELEVANT IMPLEMENTING MEASURE IN THE RELEVANT MEMBER STATE AND THE EXPRESSION "2010 PD AMENDING DIRECTIVE" MEANS DIRECTIVE 2010/73/EU. IN THE UNITED KINGDOM THIS ANNOUNCEMENT IS DIRECTED EXCLUSIVELY AT QUALIFIED INVESTORS (I) WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER") OR (II) WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, AND (III) TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED. IN CONNECTION WITH THE TRANSACTION, THE MANAGERS AND ANY OF THEIR AFFILIATES ACTING AS AN INVESTOR FOR THEIR OWN ACCOUNT MAY TAKE UP AS A PRINCIPAL POSITION ANY SHARES AND IN THAT CAPACITY MAY RETAIN, PURCHASE OR SELL FOR THEIR OWN ACCOUNT SUCH SHARES. IN ADDITION THE MANAGERS OR THEIR AFFILIATES MAY ENTER INTO FINANCING ARRANGEMENTS AND SWAPS WITH INVESTORS IN CONNECTION WITH WHICH THE MANAGERS (OR THEIR AFFILIATES) MAY FROM TIME TO TIME ACQUIRE, HOLD OR DISPOSE OF SHARES. THE MANAGERS DO NOT INTEND TO DISCLOSE THE EXTENT OF ANY SUCH INVESTMENT OR TRANSACTIONS OTHERWISE THAN IN ACCORDANCE WITH ANY LEGAL OR REGULATORY OBLIGATION TO DO SO. NO GUARANTEE CAN BE MADE THAT ANY SECURITIES WILL BE SOLD PURSUANT TO THE TRANSACTION. THE MANAGERS ARE ACTING ON BEHALF OF HANDELSBANKEN AND NO ONE ELSE IN CONNECTION WITH THE TRANSACTION AND WILL NOT BE RESPONSIBLE TO ANY OTHER PERSON FOR PROVIDING THE PROTECTIONS AFFORDED TO CLIENTS OF THE MANAGERS OR FOR PROVIDING ADVICE IN RELATION TO THE TRANSACTION.  

Nordea and DNB to combine Baltic operations

Nordea and DNB have entered into an agreement to combine their operations in Estonia, Latvia and Lithuania to create a leading main bank in the Baltics with strong Nordic roots. “Combining knowledge of the Baltic market, close cooperation with our customers and developments in digital banking, Nordea has over the years built a solid and successful bank in the Baltic region with a strong position as number three in the Baltics. Now it is time to take the next step and build for the future. Together we will have the scale, stronger geographic presence and broader product offering enabling us to become the main bank for customers in the Baltics,” says Inga Skisaker, Head of Banking Baltic Countries, Nordea. Nordea’s and DNB’s operations in the Baltics are a great match, with complementary lines of business. Nordea has built a strong position within the large corporate segment whereas DNB is strong in the SME segment. Together, the banks will also have an even larger and more competitive retail business. Furthermore, the combined bank will have a strong geographic presence, with Nordea’s strong Estonian, DNB’s strong Lithuanian and jointly strong Latvian footprints. Nordea’s and DNB’s Baltic operations have 1,300 and 1,800 employees and EUR 8 billion and EUR 5 billion in assets[1], respectively. “With over 70 branches in the Baltics, DNB have created a dynamic and customer-centric operation. Scale is key in banking today, with larger banks having more efficient use of resources. The new bank will be better equipped to counter increasing competition in the region and capitalise on scale in order to become the main bank for more businesses, customers and partners in the Baltics,” says Mats Wermelin, Head of Baltic Division, DNB. Nordea and DNB will have equal voting rights over the combined bank, while having different economic ownership levels that reflect the relative equity value of their contribution to the combined bank at the time of closing. The transaction is conditional upon regulatory approvals and conditions, and is expected to close around Q2 2017. The banks will operate independently until all necessary approvals have been received.  [1] Based on loans and receivables to the public With regard to the announcement we invite you to a press meeting. Inga Skisaker, Head of Banking Baltic Countries, Nordea and Mats Wermelin, Head of Baltic Division, DNB will participate.   Time: Thursday 25 August 11.30 CET (12.30EET). For security reasons, a valid identity card is required. To attend the press conference, please e-mail Signe Lonerte, signe.lonerte@nordea.com, +371 2911 6146.   Place: The Radisson Blu Hotel Latvija, Elizabetes 55, Riga, LatviaThe press conference will be conducted in English.  For further information:   Nordea:Signe Lonerte, Head of Communication Baltic Countries, Nordea, +371 29 11 61 46, signe.lonerte@nordea.comMagnus Nelin, Chief Press Officer, Sweden, Nordea, +46 721 45 26 40, magnus.nelin@nordea.com DNB:Thomas Midteide, Group Executive Vice President, Corporate Communications, DNB, +47 962 32 017, thomas.midteide@dnb.no   About Nordea Nordea is among the ten largest universal banks in Europe in terms of total market capitalisation and has around 11 million customers, 30,000 employees and approximately 600 branch office locations. The Nordea share is listed on the Nasdaq Stockholm, Nasdaq Helsinki and Nasdaq Copenhagen exchanges. We have a broad expertise across the wide range of products, services and solutions that we provide within banking, asset management and insurance. In Nordea we build trusted relationships through our strong engagement with both customers and society. About DNB  DNB is Norway's largest financial services group and one of the largest in the Nordic region in terms of market capitalization. The Group offers a full range of financial services, including loans, savings, advisory services, insurance and pension products for retail and corporate customers. DNB is a major operator in a number of industries, for which we also have a Nordic or international strategy. DNB is one of the world’s leading shipping banks and has a strong position in the energy sector, and the fisheries and seafood industry.

Catella – Interim Report January-June 2016

Second quarter The Group · Total income SEK 478 M (421) · Net sales SEK 475 M (419) · Operating profit/loss* SEK 65 M (46) · Operating profit/loss SEK 64 M (44) · Divestment of Visa Europe yielded non-recurring income of SEK 219 M re-ported in net financial income · Profit/loss before tax SEK 287 M (57) · Profit for the period was SEK 198 M (50), of which attributable to parent company owners SEK 182 M (48) · Earnings per share** SEK 2.23 (0.59) Corporate Finance · Total income SEK 174 M (161) · Net sales SEK 172 M (160) · Operating profit/loss* SEK 36 M (25) · Property transaction volumes SEK 20.0 Bn (15,9): · - France SEK 5.8 Bn (3.6) · - Sweden SEK 5.6 Bn (9.3) · - Germany SEK 1.3 Bn (0,8) Asset Management and Banking · Total income SEK 311 M (265) · Net sales SEK 309 M (264) · Operating profit/loss* SEK 41 M (29) · Assets under management SEK 137.9 Bn (131.8): · - increase of SEK 2.2 Bn (+0,5) · - of which net outflows SEK 0.9 Bn (+3.2) First half-year The Group · Total income SEK 940 M (839) · Net sales SEK 926 M (832) · Operating profit/loss* SEK 127 M (95) · Operating profit/loss SEK 125 M (91) · Divestment of Visa Europe yielded non-recurring income of SEK 219 M reported in net financial income · Profit/loss before tax SEK 361 M (109) · Profit for the period was SEK 253 M (93), of which attributable to parent company owners SEK 199 M (83) · Earnings per share** SEK 2.44 (1.02) · Equity SEK 1,484 M (1,177) · Equity per share** SEK 18.14 (14.40) Corporate Finance · Total income SEK 253 M (248) · Net sales SEK 245 M (246) · Operating profit/loss* SEK 24 M (11) · Property transaction volumes SEK 26.1 Bn (22.5): · - Sweden SEK 8.8 Bn (11.7) · - France SEK 7.2 Bn (6.4) · - Germany SEK 1.7 Bn (1.7) Asset Management and Banking · Total income SEK 697 M (599) · Net sales SEK 689 M (593) · Operating profit/loss* SEK 124 M (101) · Assets under management SEK 137.9 Bn (131.8): · - decrease of SEK 0.3 Bn (+9.4) · - of which net outflows SEK 2.0 Bn (+7.5) “In the second quarter, Catella’s income increased by 14% to SEK 478 M year on year. The Group’s operating profit also increased sharply, amounting to SEK 65 M, SEK 19 M up on last year. Group profit before tax was SEK 287 M, against SEK 57 M in the previous year. Profit before tax includes extraordinary income of SEK 219 M attributable to Catella Bank’s sale of shares in Visa Europe in connection with Visa Inc.’s acquisition of Visa Europe”, says Knut Pedersen, Catella’s CEO and President. The information in this Report is mandatory for Catella AB (publ) to publish in accordance with the Swedish Financial Instruments Trading Act and/or the Swedish Securities Markets Act. This information was submitted to the market for publication on 25 August 2016 at 07:00 a.m. CET.

Nel ASA: Second quarter 2016 results

(Oslo, 25 August 2016) Nel ASA (Nel) reported revenues in the second quarter of NOK 13.5 million, reflecting the fluctuating nature of Nel’s project business, as well as initiation of certain projects being postponed to the second half of 2016. The underlying project pipeline is strong and Nel has submitted a proposal for the fourth quarter allocation of the governmental hydrogen program in California. ”The second quarter was a busy period for Nel. We have introduced the next generation fueling station, the CAR-200, with orders already being placed by leading European customers. We also recently announced the new Nel C-range containerised turn-key electrolyser solution, setting the benchmark for hydrogen production efficiency and footprint. The establishment of Nel Hydrogen Solutions business area enhances market opportunities across the group, initiatives are already yielding results, and Nel is positioned at the forefront of a rapidly growing hydrogen industry”, says Jon Andrè Løkke, Chief Executive Officer of Nel.   In the second quarter of 2016, Nel reported revenues of NOK 13.5 million (Q2’15: MNOK 16.0), reflecting the fluctuating nature of the company’s project business, as well as initiation of certain projects being postponed to the second half of 2016. EBITDA ended at NOK -14.0 million (-5.3), impacted by the high activity level within business development in new markets, investments, and preparation for production ramp-up. Nel’s cash balance at the end of the second quarter was NOK 265.9 million, up from NOK 152.2 million at the end of the second quarter in 2015.   “Nel is a pure play hydrogen company with market leading technology, a strong management team, a solid balance sheet, and is positioned to play a leading role in a fast-moving industry. The underlying project development pipeline is strong and the company experiences a high activity level in ongoing tender processes,” says Løkke. In California, the Energy Commission has doubled the Governmental Grant Opportunities (GFO) hydrogen program to USD 33 million, with a target to reach 100 hydrogen fueling stations by 2020. ”Nel is taking both a direct and an indirect approach to the important California market, leveraging on delivering leading hydrogen technology. California represents an important opportunity for Nel as 33 percent of the hydrogen must be renewable, today hardly any hydrogen is made from renewables. We have submitted our California funding proposal and look forward to the governmental allocation that should take place during the fourth quarter of 2016, ” says Jon André Løkke. The presentation will be broadcasted live at www.nel-hydrogen.com/webcast and can also be viewed at http://webtv.hegnar.no/presentation.php?webcastId=36902334 The second quarter 2016 report and presentation will be made available through www.newsweb.no and www.nel-hydrogen.com. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 90 74 49 49 About Nel Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today. www.nel-hydrogen.com

CATENA MEDIA INTERIM REPORT Q2 2016

SECOND QUARTER OF 2016• Revenues totalled EUR 9.58 million (3.02), an increase of 217 percent compared with the same quarter for the previous year and an increase of 28 percent when compared to the previous quarter.• Adjusted operating profit excluding non-recurring IPO expenses amounted to EUR 5.01 million (2.28), corresponding to an adjusted operating margin of 52 percent (75). Operating profit increased to EUR 5.07 million (2.24) corresponding to an operating margin of 53 percent (74).• Profit before tax amounted to EUR 4.87 million (2.24) and excluding non-recurring IPO expenses totalled EUR 4.94 million (2.28).• New depositing customers (NDC) totalled 47,530 (15,326), an increase of 210 percent compared with the same quarter for the previous year and an increase of 47 percent when compared to the previous quarter.• Earnings per share amounted to EUR 0.08913 (0.04755). FIRST SIX MONTHS OF 2016• Revenues totalled EUR 17.04 million (4.98), an increase of 242 percent compared with the same period for the previous year.• Adjusted operating profit excluding non-recurring IPO expenses amounted to EUR 9.17 million (3.46), corresponding to an adjusted operating margin of 54 percent (70). Operating profit increased to EUR 8.25 million (3.42) corresponding to an operating margin of 48 percent (69).• Profit before tax amounted to EUR 8.70 million (3.43) and excluding non-recurring IPO expenses totalled EUR 9.61 million (3.47).• New depositing customers (NDC) totalled 79,851 (25,176), an increase of 217 percent compared with the same period for the previous year.• Earnings per share amounted to EUR 0.16401 (0.07520). SIGNIFICANT EVENTS DURING THE SECOND QUARTER• On 3 April 2016, Catena Media acquired the acknowledged and highly regarded affiliate website AskGamblers.com for a consideration of EUR 15 million. The transaction is the largest in Catena Media’s history. AskGamblers operates one of the markets’ most highly visited web portals for player reviews and rankings of online casinos. The company also provides players with the unique opportunity of trying online casino-related disputes via the portal. Players across Europe utilise AskGamblers.com with the UK being the company’s largest market. The transaction comprises all affiliate accounts, domains, mobile apps and social media accounts.• On 2 June 2016, Catena Media acquired the player accounts and domains of one of the leading iGaming affiliates in Germany. The purchase price, maximised at EUR 6.5 million, comprises an upfront payment of EUR 3.5 million and an earn-out, based on the first-year revenue performance, of a maximum of EUR 3.0 million. To achieve the maximum earn-out, the seller needs to generate substantial revenue growth.• On 19 June 2016, with an effective date of 1 July 2016, Catena Media continued to pave the way in becoming the leading iGaming lead generation group through the acquisition of the player accounts and domains of a Swedish sportsbook affiliate Spelbloggare.se. The purchase price amounted to EUR 2.50 million, with an additional earn-out of a maximum of EUR 2.50 million. For the maximum earn-out to be reached, the seller needs to generate substantial revenue growth.• Catena Media has in recent weeks also launched its own sportsbook affiliate product in the UK. Through this launch and the acquisition of Spelbloggare.se, Catena Media made an entry into the sportsbook segment – a new vertical for the Group. • During the quarter, Catena Media also recruited key expertise to the Board of Directors. Kathryn Moore Baker, with extensive experience in building successful companies from an active board and Chairperson position, has taken over as Chairperson, while Mathias Hermansson, CFO with MTG Group for many years, has been elected to the Board. After the quarter, the management team was further strengthened through the recruitment of Owe Laestadius (CTO). Owe Laestadius has 15 years of experience in the iGaming industry, mainly in leading engineering roles at Betsson Group. Other recruitments were Anne Rhenman Eklund as Head of IR/Communication, Louise Wendel as Head of Legal and Nikola Teofilovic as the new General Manager for Serbia.• Furthermore, Catena Media has begun preparations for a move from Nasdaq First North Premiere to the Stockholm Stock Exchange’s main list (Mid Cap). The work is proceeding according to plan. CEO COMMENT We grow bigger and stronger, day by day Continued aggressive expansion and successful integration of acquisitions generated strong growth and solid second quarter results. During the second quarter of 2016, the focus has been on further expanding Catena Media, both in terms of geographies and products. It has been an exciting and eventful period that included several new acquisitions, a new venture in the sportsbook segment, entry into the large German market and further reinforcement of both the management team and the Board of Directors. The high growth rate that has distinguished the company since its start in 2012 continues to be evident, with the normal second quarter negative seasonal effect – mainly within Paid revenue – only barely notable. In the second quarter, sales grew 217 percent compared to the same period in 2015 and 28 percent compared with the first quarter this year. From a market perspective, the second quarter mirrored the European Football Championship, where casino was somewhat overshadowed by sports betting – a vertical where we are currently, a small but fast-growing player. In Paid revenue, particularly in sports betting, we have increased the amount of players on revenue share giving an inherent delayed effect, with the result of our efforts remaining to be seen moving forward. Regarding the development in the UK (Brexit), with a weakening of the pound sterling, we have noted no impact on our revenues but some positive effects on our operating profit. Strategically important acquisitionsDuring the quarter, we made several strategic acquisitions that have broadened Catena Media’s offering, and thus opened up substantial, new opportunities for growth. The acquisition of AskGamblers.com, a major international brand with a strong community, comprises our biggest acquisition to date and a strategically important step for Catena Media. AskGamblers.com has a strong mobile platform and creates considerable possibilities for us to build a development centre with an attractive cost base. Furthermore, we have entered the sizeable sports betting segment through the acquisition of Spelbloggare.se, which was consolidated on the 1 July. We also launched our own sportsbook affiliate product in the UK. In addition, we have acquired the essential assets of a German affiliate company, which means that we have established ourselves in the large and important German market. These initiatives have enabled us to further strengthen our position as one of the leading players in lead generation in iGaming. We are pleased to note that the acquisitions we have made during the year have been integrated according to plan, with a clear revenue boost generated by the Catena technical platform. We will continue to work toward our vision through our proven model of acquisition with rapidly realised synergies combined with organic expansion. Growth ahead, top recruitments and preparation for the main listThe Catena Media growth story remains solid. We have a positive outlook for the third quarter, with indications of growth in line with our financial targets. As we grow, we also have an increasing need for talented and experienced people, as well as additional capital, that can help Catena Media take advantage of the opportunities ahead and to the next step in our development. We are therefore pleased with the recently announced new recruitments to the Board and to management. These appointments have an added dimension as Catena Media has begun preparations for moving to the Stockholm Stock Exchange’s main list (Mid Cap) in 2017, for which the work is proceeding according to plan. In addition, we have started review the possibility to raise capital through a bond issue to continue to support the long term strategy of the Group. Robert Andersson, CEO

NetEnt launches games with The Rank Group Plc

The Rank Group Plc is one of the largest gaming companies in Europe with a strong market presence in the UK and with well-known brands such as Grosvenor Casinos (www.grosvenorcasinos.com) and Mecca (www.meccabingo.com). For more information about the agreement with Rank Group, please see the press release from June 2016: https://www.netent.com/en/netent-signs-customer-agreement-with-the-rank-group-plc/ For additional information please contact:Enrico Bradamante, MD of NetEnt Malta Ltd and Chief of European Market Operations Phone: +356 79 676 868enrico.bradamante@netent.com Roland Glasfors, Investor Relations, NetEnt AB (publ)Phone +46 760 024 863roland.glasfors@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on August 25, 2016. About NetEntNetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ Stockholm (NET–B) and employs 800 people in Stockholm, Malta, Kiev, Krakow, Gothenburg, Gibraltar and New Jersey. www.netent.com

Handelsbanken has divested all of its A-shares in Industrivärden

Svenska Handelsbanken AB (publ) (“Handelsbanken”) has today sold all of its A-shares, 29,367,821 Class A shares in AB Industrivärden (publ) (“Industrivärden”), corresponding to 6.8 per cent of Industrivärden’s share capital and 10.3 per cent of the voting rights. The price is set to SEK 153.25 per share (the “Transaction”). The shares have been acquired by Swedish and international institutional investors. The Transaction will result in a capital gain for Handelsbanken of approximately SEK 750 million, which will have a positive impact on Handelsbanken’s earnings in the third quarter of 2016. The divestment will not result in any increase in Handelsbanken’s equity, as the shares were recognized as an available-for-sale asset at market value in the bank’s accounts. As a result of the Transaction, Handelsbanken’s risk exposure amount will decrease and the expected positive impact on Handelsbanken’s common equity tier 1 ratio is estimated at approximately 0.6 percentage points. Morgan Stanley and Handelsbanken Capital Markets acted as Joint Bookrunners in the Transaction. For further information, please contact: Ulf Riese, Chief Financial Officer, + 46 8 – 22 92 20Mikael Hallåker, Head of Investor Relations, + 46 8 – 701 29 95, + 46 70 – 266 29 95Johan Wallqvist, Head of Media Relations, +46 8 – 701 10 00, + 46 72 – 206 34 50 This information is of the type that Handelsbanken is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication through the agency of the contact person set out above, on 25 August 2016 at 07.30 a.m. CET. For more information about Handelsbanken, see: www.handelsbanken.com (http://www.handelsbanken.se/)  IMPORTANT NOTICE   THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL, OR SOLICITATION OF AN OFFER TO BUY, ANY SECURITIES IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") AND MAY NOT BE SOLD IN THE UNITED STATES ABSENT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE WILL NOT BE A PUBLIC OFFERING OF THE SHARES IN THE UNITED STATES. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES OR INVESTMENTS FOR SALE OR A SOLICITATION OF AN OFFER TO BUY SECURITIES OR INVESTMENTS IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION  WOULD BE UNLAWFUL. NO ACTION HAS BEEN TAKEN THAT WOULD PERMIT AN OFFERING OF THE SECURITIES OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUIRED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY SUCH RESTRICTIONS. ANY FAILURE TO COMPLY WITH  THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF ANY SUCH JURISDICTION. IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA ("EEA") WHICH HAVE IMPLEMENTED THE PROSPECTUS DIRECTIVE (EACH, A "RELEVANT MEMBER STATE"), THIS ANNOUNCEMENT AND ANY OFFER IF MADE SUBSEQUENTLY IS DIRECTED EXCLUSIVELY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF THE PROSPECTUS DIRECTIVE ("QUALIFIED INVESTORS"). FOR THESE PURPOSES, THE EXPRESSION "PROSPECTUS DIRECTIVE" MEANS DIRECTIVE 2003/71/EC (AND AMENDMENTS THERETO, INCLUDING THE 2010 PD AMENDING DIRECTIVE, TO THE EXTENT IMPLEMENTED IN A RELEVANT MEMBER STATE), AND INCLUDES ANY RELEVANT IMPLEMENTING MEASURE IN THE RELEVANT MEMBER STATE AND THE EXPRESSION "2010 PD AMENDING DIRECTIVE" MEANS DIRECTIVE 2010/73/EU. IN THE UNITED KINGDOM THIS ANNOUNCEMENT IS DIRECTED EXCLUSIVELY AT QUALIFIED INVESTORS (I) WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER") OR (II) WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, AND (III) TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED. IN CONNECTION WITH THE TRANSACTION, THE MANAGERS AND ANY OF THEIR AFFILIATES ACTING AS AN INVESTOR FOR THEIR OWN ACCOUNT MAY TAKE UP AS A PRINCIPAL POSITION ANY SHARES AND IN THAT CAPACITY MAY RETAIN, PURCHASE OR SELL FOR THEIR OWN ACCOUNT SUCH SHARES. IN ADDITION THE MANAGERS OR THEIR AFFILIATES MAY ENTER INTO FINANCING ARRANGEMENTS AND SWAPS WITH INVESTORS IN CONNECTION WITH WHICH THE MANAGERS (OR THEIR AFFILIATES) MAY FROM TIME TO TIME ACQUIRE, HOLD OR DISPOSE OF SHARES. THE MANAGERS DO NOT INTEND TO DISCLOSE THE EXTENT OF ANY SUCH INVESTMENT OR TRANSACTIONS OTHERWISE THAN IN ACCORDANCE WITH ANY LEGAL OR REGULATORY OBLIGATION TO DO SO. NO GUARANTEE CAN BE MADE THAT ANY SECURITIES WILL BE SOLD PURSUANT TO THE TRANSACTION. THE MANAGERS ARE ACTING ON BEHALF OF HANDELSBANKEN AND NO ONE ELSE IN CONNECTION WITH THE TRANSACTION AND WILL NOT BE RESPONSIBLE TO ANY OTHER PERSON FOR PROVIDING THE PROTECTIONS AFFORDED TO CLIENTS OF THE MANAGERS OR FOR PROVIDING ADVICE IN RELATION TO THE TRANSACTION.   Forward-Looking Statements Matters discussed in this communication may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as “believe,” “expect,” “anticipate,” “intend,” “may,” “plan,” “estimate,” “will,” “should,” “could,” “aim” or “might,” or, in each case, their negative, or similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurances that they will materialize or prove to be correct. Because these statements are based on assumptions or estimates and are subject to risks and uncertainties, the actual results or outcome could differ materially from those set out in the forward-looking statements as a result of many factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The Company does not guarantee that the assumptions underlying the forward-looking statements in this presentation are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or any obligation to update or revise the statements in this presentation to reflect subsequent events. Undue reliance should not be placed on the forward-looking statements in this document. The information, opinions and forward-looking statements contained in this communication speak only as at its date, and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm, or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this communication. 

SAF-HOLLAND withdraws all-cash offer for Haldex AB

Luxembourg, 25 August 2016 - SAF-HOLLAND GmbH (“SAF-HOLLAND”), a wholly-owned subsidiary of SAF-HOLLAND S.A., announced an all-cash offer for Haldex AB (publ) (“Haldex”) in the amount of SEK 94.42 per Haldex share on 14 July 2016 (the “Offer”). On 11 August 2016, SAF-HOLLAND gave notice, in light of a higher offer announced by another bidder on 4 August 2016, that the Offer price would not be increased. The acceptance period for the Offer ended on 24 August 2016. As of the end of the acceptance period, 199,461 Haldex shares, representing 0.45 per cent of the outstanding shares and votes, had been tendered. Completion of the Offer was, among other things, conditional upon the offer being accepted by Haldex’ shareholders to such an extent that SAF-HOLLAND would become the owner of shares representing more than 90 per cent of the outstanding shares in Haldex. This condition has not been satisfied. Thus, SAF-HOLLAND has decided to withdraw the Offer. Accordingly, the shares tendered will not be acquired by SAF-HOLLAND and will remain in the respective holders’ ownership without any action needed on the part of the shareholder. As previously communicated, SAF-HOLLAND is holding 1,590,000 shares in Haldex, representing 3.6 per cent of the outstanding shares and votes, following purchases prior to the Offer announcement. SAF-HOLLAND remains commited to generating value for all its stakeholders and delivering on its Strategy 2020. The Group sees itself very well positioned as it operates on the basis of a strong business model and long-standing relationships to its customers. Furthermore, it has a number of strategic initiatives underway to further expand its market presence and generate profitable growth. SAF-HOLLAND Profile:SAF-HOLLAND S.A., located in Luxembourg, is the largest independent listed supplier to the commercial vehicle market in Europe. With sales of approximately EUR 1,060 million in 2015 and more than 3,100 employees, the company is one of the world’s leading manufacturers and suppliers of chassis-related systems and components primarily for trailers, trucks, buses, and recreational vehicles. The product range comprises axle and suspension systems, fifth wheels, kingpins, and landing gear and is marketed under the brands SAF, HOLLAND, and Neway. SAF-HOLLAND sells its products to Original Equipment Manufacturers (OEMs) on six continents. The Group's Aftermarket business sells spare parts to the service networks of Original Equipment Suppliers (OES), as well as to end customers and service centers through its extensive global network of parts distribution centers. SAF-HOLLAND is one of the few suppliers in the truck and trailer industry that is internationally positioned in almost all markets worldwide.  SAF-HOLLAND contact for investors/analystsStephan HaasTelephone: +49 (0)6095 301 617Email: stephan.haas@safholland.de Christina HüttnerTelephone: +49 (0)6095 301 255Email: christina.huettner@safholland.de  Contact for Swedish media and investorsNarvaFrank BaggeTelephone: +46 (0) 76 006 24 76Email: frank.bagge@narva.se (hans.westerberg@narva.se)  Olof EhrsTelephone: +46 (0) 70 481 72 34Email: olof.ehrs@narva.se Contact for German media and additional contact for investorsFTI Consulting Carolin AmannTel: +49 (0) 69 92037 132Email: carolin.amann@fticonsulting.com  Anja MeuselTel: +49 (0) 69 92037 120Email: anja.meusel@fticonsulting.com  This press release was submitted for publication on 25 August 2016 at 7:30 (CEST). Important noticeThis is a translation of the original Swedish language press release. In the event of discrepancies, the original Swedish wording shall prevail. The distribution of this press release and any related offer documentation in certain jurisdictions may be restricted or affected by the laws of such jurisdictions. Accordingly, copies of this communication are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any such jurisdiction. Therefore, persons who receive this communication (including, without limitation, nominees, trustees and custodians) and are subject to the laws of any such jurisdiction will need to inform themselves about, and observe, any applicable restrictions or requirements. Any failure to do so may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, SAF-HOLLAND disclaims any responsibility or liability for the violations of any such restrictions by any person. The offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or any other jurisdiction in which the making of the offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. Statements in this press release relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “intends”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of SAF-HOLLAND and Haldex. Any such forward-looking statements speak only as of the date on which they are made and SAF-HOLLAND has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations. Notice to shareholders in the United StatesThe offer is being made for the securities of a Swedish company and is subject to Swedish disclosure requirements, which are different from those in the United States. Also, the settlement procedure with respect to the offer will comply with Swedish law, which differs from US domestic tender procedures in certain material respects, particularly with regard to the date of payment of consideration. The offer is being made in reliance upon exemptions afforded by Rule 14d-1(c) under the US Securities Exchange Act of 1934. It may be difficult for investors in the United States to enforce their rights and any claim they may have arising under federal securities laws since the companies are located in a non-US jurisdiction, and some or all of their officers may be residents of non-US jurisdictions. Such US investors may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. It may be difficult to compel a non-US company and its affiliates to subject themselves to a US court’s judgment. In accordance with normal Swedish market practice, SAF-HOLLAND, its nominees or its brokers (acting as agents) may from time to time make certain acquisitions or arrangements to acquire Haldex shares outside the United States, other than pursuant to the offer, before the offer commences and through the expiration of the offer. These acquisitions may occur either in the open market at prevailing prices or in private transactions at negotiated prices. Any information about such acquisitions will be disclosed to the extent required by Swedish law or rules or regulations. The offer in the United States is being made solely by SAF-HOLLAND and not by any other person.  

Raysearch Laboratories AB (publ) Interim report January 1 – June 30, 2016

“Revenues from RayStation® rose 100 percent to SEK 107.8 M (53.9) and prospects are favorable for the rest of the year.The development of RayCare® is progressing as planned and we will demonstrate the system at the 2016 ASTRO radiation therapy conference in Boston at the end of September,” says Johan Löf, President and CEO of RaySearch. SECOND QUARTER (APRIL - JUNE 2016) · Net sales SEK 119.0 M (77.3), of which RayStation SEK 107.8 M (53.9) · Profit after tax SEK 28.8 M (loss: 2.6) and earnings per share were SEK 0.84 (loss: 0.08) · Operating profit SEK 37.5 M (loss: 2.1) · Cash flow negative SEK 21.0 M (neg: 10.1) · Order intake excl. service agreements SEK 129.1 M (72.0), of which RayStation SEK 120.8 M (55.3) · Order backlog for RayStation was SEK 65.2 M (40.2) at the end of the period HALF-YEAR (JANUARY - JUNE, 2016) · Net sales SEK 214.4 M (165.1), of which RayStation SEK 188.6 M (116.6) · Profit after tax SEK 46.6 M (22.4), and earnings per share SEK 1.36 (0.65) · Operating profit SEK 60.8 M (31.0) · Cash flow negative SEK 26.3 M (neg: 2.3) · Order intake excluding service agreements SEK 211.0 M (158.3), of which RayStation SEK 193.4 M (124.4) SIGNIFICANT EVENTS DURING THE SECOND QUARTER · RaySearch has continued to secure more major orders from some of the world’s largest and most respected cancer clinics, including the University of California San Francisco and the Miami Cancer Institute in the US, a number of proton clinics in Japan, and the Holland Particle Therapy Centre in the Netherlands. SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD · Victoria Sörving, General Counsel, has decided to leave the company effective September. ABOUT RAYSEARCH RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch develops and markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is currently used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003. More information about RaySearch is available at www.raysearchlabs.com. FOR FURTHER INFORMATION, PLEASE CONTACT: Johan Löf, Tel: +46 8 E-mail: johan.lof@raysearchlabs.com President and 510 530 00 CEO  Peter Thysell, Tel: +46 E-mail: peter.thysell@raysearchlabs.com CFO  70 661 05 59

Recipharm increases lyophilisation capacity in Italy

The investment forms part of Recipharm’s strategy to become a leading lyophilisation provider, and is in addition to the ongoing investment at Recipharm in Wasserburg, Germany, where a further €32 million is currently being spent to increase capacity. Specialising in aseptic manufacturing and filling of parenterals, Recipharm in Masate, located close to Milan, offers lyophilisation capabilities in both vials and ampoules. The investment will see the introduction of a new lyophiliser for vials, bringing the total number of machines from five to six and increasing the facility’s capacity by approximately 20 per cent. The new machine will allow the CDMO to support more drug developers with their stability challenges and meet growing demand for its lyophilisation services, particularly in Europe, China and Japan. Commenting on the investment, General Manager Giorgio Bruno said: “We are experiencing greater demand for lyophilisation capabilities from our customers, ranging from some of the largest pharmaceutical companies to small and mid-sized firms. As we continue to receive more requests from existing customers and new enquiries from drug developers in new territories, we needed to increase our capacity”. Contact informationGiorgio Bruno, General Manager, giorgio.bruno@recipharm.com, +39 3358100229Kjell Johansson, President Manufacturing Services Europe, kjell.johansson@recipharm.com, + 46 739 622620 For media enquiries, please contact Lindsay Baldry at ramarketing: lindsay@ramarketingpr.com,+ 44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr,Linkedin: /ramarketing About RecipharmRecipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 3,500 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm’s turnover is approximately SEK 5.0 billion and the Company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.For more information on Recipharm and its services, please visit www.recipharm.com

Cherry Interim Report 2 2016, 1 January- 30 June 2016

Highlights Second quarter: Revenues grew to MSEK 191.7 (+80%) – Acquisition of ComeOn ·  Group revenue increased by 80 percent to MSEK 191.7 (106.7). Online made up 81 percent (63) of the group revenues.  ·  Profitability improved considerably and EBITDA amounted to MSEK 14.8 (-0.4). EBIT amounted to MSEK 6.0 (-5.2). The result was burdened with acquisition costs for ComeOn and Nasdaq listing costs of MSEK 4.0. ·  The result after tax was MSEK 8.4 (-6.8), equivalent to SEK 0.21 (-0.52) per share after dilution and minority interests.  ·  Online Gaming grew by 113 percent and EBITDA amounted to MSEK 8.6 (-2.3). The figures are not including ComeOn. ·  Yggdrasil Gaming grew by 810 percent and EBITDA amounted to MSEK 9.8 (-1.2).   ·  Restaurant Casino’s turnover amounted to MSEK 35.9 (39.6) and EBITDA amounted to MSEK 3.1 (5.3). The decrease is due to seasonality effects in terms of when holidays occurred during the second quarter. ·  Cherry signed an agreement regarding the purchase of 49% of the shares in ComeOn Malta Ltd with an option to acquire the remaining 51%. The acquisition means that Cherry’s position will strengthen considerably in the Scandinavian market. ComeOn’s management expects a turnover of between MSEK 930 and MSEK 1,130 and an EBIT of between MSEK 180 and MSEK 220 for 2016. The acquisition is expected to have a significantly positive effect on Cherry’s earnings per share from 20 July 2016. ·  In June, Yggdrasil Gaming was awarded an operator’s licence by the Gibraltar Regulatory Authority. ·  Yggdrasil signed agreements with five new operators, including bwin.party and Interwetten. ·  The Group’s consolidated cash amounted to MSEK 67.8 (24.7) at the end of the second quarter 2016.  Six-month interim period: Revenues increased to MSEK 369.0 (+83%) with a positive EBITDA of MSEK 40.5  ·  Group turnover increased by 83 percent compared to the previous year and amounted to MSEK 369.0 (202.0). Online made up 80 percent (63) of the group revenue. ·  Profitability improved considerably and EBITDA amounted to MSEK 40.5 (-4.9). EBIT amounted to MSEK 23.5 (-14.1). ·  The result after tax amounted to MSEK 25.9 (-18.6) equivalent to SEK 1.01 (-1.40) per share after dilution & minority int. ·  Online Gaming grew by 115 percent and EBITDA amounted to MSEK 25.1 (-8.0). The figures are not including ComeOn. ·  Yggdrasil Gaming grew by 661 percent and EBITDA amounted to MSEK 17.7 (-1.6).  ·  Restaurant Casino had a turnover in line with the previous year and EBITDA amounted to MSEK 7.6 (9.2). Important events after the end of the quarter ·  On 20 July, Cherry acquired 49 percent of the shares in ComeOn Malta Ltd. ·  The site EuroSlots has been relaunched and will have increased marketing exposure thanks to a cooperation with the Malta- and Denmark-based Power Media Group and their affiliate network Matching Visions. ·  In August, Yggdrasil Gaming went live with the world’s largest gaming operator, bet365. ·  In August, Cherry-owned Game Lounge acquired the assets of renowned affiliate company Interclick Limited, which has been active in the German and British markets for 14 years. The purchase price amounts to MUSD 1.5 and Game Lounge acquires around 40 domains and affiliate accounts. The acquisition is expected to have a payback time of less than 1.5 years and is expected to increase turnover by approximately MEUR 1.3 and EBITDA by MEUR 1.0 per year. CEO comments second quarterCherry continued to deliver according to its strategy, which combines strong organic growth with strategic acquisitions. The second quarter shows continued strong growth and a significant increase in profits. In the second quarter, the Group’s growth reached 80 percent. Cherry's online activities continue to grow considerably faster than the market, now representing 81 percent (63) of Group sales, and we henceforth expect to grow faster than the market. During the quarter, Cherry announced the acquisition of 49 percent of ComeOn and the transaction was finalised on July 20. The acquisition means that Cherry strengthens its position in online gaming against our competitors in both Scandinavian and European markets, while at the same time adding strong brands. Cherry reinforces its customer base in sports betting, which accounts for about one third of ComeOn’s turnover. Both the business areas Online Gaming - Cherry iGaming and ComeOn are growing considerably faster than the market with good profitability and this allows for further investment in existing brands with continued expansion in new markets. Alongside ComeOn’s management and its founders, the work to quickly maximise common values and offerings has begun and the integration process is ongoing. For the second quarter, ComeOn reports a 31 percent growth, a preliminary turnover of approximately MSEK 225 and an EBIT amounting to about MSEK 53. If, for the second quarter in 2016, Cherry Group and ComeOn figures were consolidated, the combined turnover would amount to approximately MSEK 403 and EBITDA to around MSEK 68. For 2016, ComeOn’s management expects a turnover of between MSEK 930 to MSEK 1,130 and an operating profit of between MSEK 180 and MSEK 220 million. The acquisition is expected to have a significant positive effect on earnings per share already this year.  During the second quarter, Cherry's business area Online Gaming - Cherry iGaming enjoyed very strong growth of 113 percent. The activity on our gaming sites grew strongly and the number of active customers increased by as much as 202 percent. Compared to the second quarter of 2015, deposits increased by 110 percent. During the quarter, the gaming surplus from mobile devices increased by 72 percent. Marketing activities intensified during the quarter and increased to MSEK 47.0 (23.5), which represented 34 percent of Online Gaming revenues for the second quarter. During the period, we continued to upgrade our gaming sites with our latest technology and new product verticals. Among many things, Lotto was introduced on CherryCasino and sports betting was implemented on Sunmaker. After the quarter, EuroSlots teamed up with a large master affiliate and the site has been updated with the latest technology. The affiliate company Game Lounge continues to develop positively. The acquisition of the assets of prestigious company Interclick Ltd will increase affiliate revenues and help Game Lounge enter both the German and the English markets, which is well in line with Cherry iGaming’s expansion plans. Cherry iGaming will, in addition to the licences it already has, continue to seek local licences where we expect strong growth, and we have also initiated an application process to obtain an operator's license in the UK, which is expected to be in place during the second half of 2016. Today, Cherry iGaming is well positioned with a platform that makes it possible to quickly and efficiently add new products and skins. Game development - Yggdrasil Gaming - continued to experience outstanding performance in the second quarter, as revenues grew by 810 percent and the EBITDA margin amounted to 49 percent. During the second quarter, bet turnover increased by 1,434 percent. Mobile gaming accounted for 48 percent (25) of the total Gross Game Win. During the quarter, Yggdrasil received a licence for the jurisdiction of Gibraltar, from where a number of major game operators operate. During the quarter, three new innovative quality games were delivered, which were well received by both customers and operators and five new agreements were signed with operators including bwin.party and Interwetten. In June 2016, Yggdrasil was named "Slot Provider of the Year" at the EGR B2B Awards in London, which is recognition of the company's market-leading portfolio of video slots. After the quarter, Yggdrasil, launched another new innovative and industry-first promotional tool, "BRAG", which allows players to share their gaming on social media. In August, Yggdrasil also went live with the world's largest gaming operator bet365. As new operators are deployed, more games are launched at existing customers and the game portfolio grows, Yggdrasil revenues continue to increase. Restaurant Casino - Cherry Spelglädje - continues to deliver solid results despite poorly timed holidays that have had a negative impact on turnover. During the quarter, we undertook a significant recruitment of croupiers. A new site - Cherry Spelglädje (http://cherryspelgladje.se/) – was also launched, to continue attracting the best employees. Cherry is the only private gaming company included in the reference group for new gaming legislation in Sweden, and Cherry attended the Almedalen week political forum to discuss the important issue of raising stake size with interested politicians. As previously announced, Cherry has applied for a listing on the Nasdaq Stockholm stock exchange, a task that has been postponed in favour of the acquisition of ComeOn. Now resources have been freed up for this important task, the ambition is still to be listed during 2016. Our ambition is to continue to grow faster than the market and we are well equipped to do this both through organic growth and acquisitions. Our strategy, in combination with differentiated business areas, will create excellent opportunities for continued high growth, high profitability and strong value growth. We look forward to continue to spread the joy of playing, both online and at the pub! Fredrik Burvall, CEO   For further information please see the full Interim Report 2016. http://cherry.se/en/financial-reports/ TranslationThis is a translation of the Swedish original. For further information, please contact:Fredrik Burvall, CEO Cherry AB (publ), telephone +46 8-514 969 52, +46 709 279 632, Email: fredrik.burvall@cherry.se Gunnar Modalen, Head of Investor Relations & Communication Cherry AB (publ), telephone +46 702 802 636, gunnar.modalen@cherry.se

BLACKSTONE: FULFILMENT OF CONDITIONS PRECEDENT TO ACQUIRE 40 PER CENT OF THE VOTING RIGHTS AND 32 PER CENT OF THE SHARE CAPITAL IN D. CARNEGIE & CO

On July 15, 2016 Blackstone Real Estate Partners Europe IV and Blackstone Real Estate Partners VIII (jointly "Blackstone") announced that Blackstone, through its entity Vega Holdco Sarl ("Vega Holdco"), had entered into agreements with three of D. Carnegie & Co's largest shareholders Kvalitena AB (“Kvalitena”), Svensk Bolig Holding AB (”SBH”), and Frasdale Int. BV (“Frasdale”) to acquire part of or all of their shareholdings, corresponding to 40 per cent of the voting rights and 32 per cent of the share capital in D. Carnegie & Co, at a price of SEK 100.00 per share. In addition, Kvalitena and Frasdale agreed to Blackstone exercising the voting rights of their remaining shares in D. Carnegie & Co, resulting in Blackstone, following completion of the transactions, controlling a total of 53 per cent of the voting rights in D. Carnegie & Co. The completion of the transactions was subject to customary merger clearance and certain other third party approvals. Blackstone hereby announces that the conditions have been fulfilled and that the full completion of the transactions, which might occur in steps, is expected to occur by early November. The transactions will, when fully completed, result in Blackstone passing the threshold for a mandatory offer obligation. Blackstone will revert with further information regarding a possible mandatory tender offer in connection with the completion of the transactions.  Bank of America Merrill Lynch and Leimdörfer acted as financial advisers and Roschier Advokatbyrå acted as legal adviser to Blackstone on the transactions. The information was submitted for publication on August 25, 2016 at 08.00 a.m. (CET). For additional queries, please contact: Andrew Dowler +44 (0)20 7451 4275 andrew.dowler@blackstone.com For Nordic media: JKL +46-73 503 12 86, blackstone@jklgroup.com About Blackstone Real Estate Blackstone is a global leader in real estate investing. Blackstone’s real estate business was founded in 1991 and has over $100 billion in investor capital under management. Blackstone’s real estate portfolio includes hotel, office, retail, industrial and residential properties in the US, Europe, Asia and Latin America. Major holdings include Hilton Worldwide, Invitation Homes (which manages nearly 50,000 single-family homes in the United States), LivCor (which manages over 36,000 multi-family units in the United States), Logicor (pan-European logistics), and prime office buildings in the world’s major cities.

WntResearch provides update from the ongoing phase 1b-study with Foxy-5

Next to the primary study centre in Denmark, dosage of patients has recently been able to commence at the Northern Centre for Cancer Care (NCC), Freeman Hospital in Newcastle, UK. After deliberations with the Swedish Medical Products Agency, WntResearch has decided to refrain from the previously planned expansion of the study to Skåne’s University Hospital. The reasoning behind the decision is that a new formulation of Foxy-5 which is going to be used for the phase 2 study, was also intended to be used for the Swedish part of the study, and this drug substance will not become available until next year. ”It is satisfying that the study advances according to plan at our primary study centres in Denmark and that the first patients can now be included at Freeman Hospital in Newcastle, UK. The results of the study will give us an important platform for further decisions, well ahead of time before the start of a phase 2-trial next year.”, says Henrik Lawaetz, CEO at WntResearch. The Phase 1b-study with Foxy-5 is being undertaken in patients with advanced and metastasised colon, prostate or breast cancer who’s primary tumour express no or low level Wnt-5a. The primary purpose of the phase 1b-study is to create a solid basis for decision on which dosage levels that should be included in the coming phase 2 study that is expected to start during 2017. For further information contact:Henrik Lawaetz, CEOE-mail: hl@wntresearch.comTelephone: +46 72 702 4694 About WntResearchWntResearch is developing a new type of cancer treatment based on pioneering research, which shows that the endogenous protein Wnt-5a plays a crucial role for tumour cells’ ability to relocate and spread inside the body. Most patients that die of cancer do so not due to the primary tumour, but due to metastasises and the need for a specific treatment to counteract metastasis is therefore in high demand. WntResearch’s most advanced drug candidate Foxy-5 has in preclinical tests been shown to reduce tumour cells’ mobility and thereby counteract the occurrence of metastasis. The results from a completed phase 1-study show a favourable security profile and pharmacokinetics as well as early indications of biological activity. A phase 1b-study is currently ongoing in patients with cancer in colon, prostate and breast. WntResearch is a public company listed at AktieTorget in Stockholm, Sweden. For further information: www.wntresearch.com

Senzime in collaboration with Örebro University

The so-called inflammasome is a relatively newly discovered protein complex, which has a key role in the immune system, is a cellular engine that helps the body's immune system to detect various substances that can be a threat and protect the body against infections. One in three people have inflammasomes that are easily triggered. This risk factor, which drives an inflammatory process, can affect some people when other are not; their immune system overreacts and become harmful. The collaboration with Örebro University seeks to explain how inflammasomes work in different medical situations, with different stimuli and in different individuals. Researchers at Örebro University have received SEK 11 million from the KK Foundation, and together with four companies, including Senzime; the aim is to explain why the immune system reacts differently in different individuals. For Senzime this is an important partnership in which the company will access researchers and Örebro University network and be a part of leading research in inflammation in order to understand why some individuals are more likely to become ill after an operation and also to present new clinical data. "Senzime will deliver products to the healthcare market that contribute to improved patient safety and reduced health care costs. The collaboration with Örebro University aims to do achieve this and we will, with resources, instruments, consumables and microdialysis probes, help to increase knowledge of inflammasomes, thereby early identifying patients with higher risk of becoming ill after an operation, during an infection or because of polluted air, "says Lena Söderström, CEO of Senzime AB. For further information, please contact: Lena Söderström, CEO of Senzime ABTel: +46-708-16 39 12, email: lena.soderstrom@senzime.com TO THE EDITORSAbout Senzime Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of $10 billion. The company's shares are listed on AktieTorget (ATORG: SEZI) www.senzime.com 

Environmental pioneer Viking Grace marks 1,000 LNG bunkerings

One thousand bunkerings via the M/S Seagas The M/S Seagas, which was specially built for ship-to-ship refuelling, has performed its 1,000th LNG bunkering of the Viking Grace since that vessel was placed in service in January 2013. The Seagas supplies the Viking Grace with about 60 tonnes of LNG while the vessel is docked in the morning at Stadsgården in central Stockholm. The Seagas is the first vessel of its kind in the world and is classified according to the same regulations as for ocean-going LNG tankers. Viking Line’s wish was for bunkering to occur as quickly as possible, with no interruptions, with assured deliveries and without affecting cargo handling on the quay. With its safe LNG bunker solution using the Seagas, AGA could meet Viking Line’s needs. The safety aspect was also extremely important in this context. “We are really pleased about having used LNG to fuel the M/S Viking Grace”, says Jan Hanses, President and CEO of Viking Line Abp. “Both the technical solution developed by AGA and the vessel’s operation have outperformed expectations, and it is gratifying to note the major benefits for the workplace along with the environmental gains that running on LNG provides.”    “We are obviously delighted with the positive response we have had from Viking Line regarding the Seagas and our bunkering solution”, says Jonas Åkermark, who is in charge of the LNG marine market at AGA Gas AB. “There is still heavy interest in the Seagas, our ship-to-ship bunkering solution and LNG as a marine fuel both in Sweden and internationally. We have a well-functioning infrastructure solution in place in Stockholm and the possibility of bunkering more vessels.” Positive response In February 2012, Viking Line signed an agreement with AGA Gas AB for the delivery of liquefied natural gas (LNG) for its newly ordered passenger vessel the Viking Grace. With its strong environmental profile, the ship was a trailblazer in the marine industry, going into service less than a year later, in January 2013. There were many unanswered questions, including how the gas would actually be supplied to the vessel and the attitude of customers towards what, for them, was a new type of fuel. Among the steps it took to ensure it was well prepared, Viking Line put together factsheets about the properties of the gas. The company expected some degree of scepticism, but in retrospect the response was incredibly positive. Viking Line received a very favourable response to the fuel alternative it had chosen and for the environmental values that the Viking Grace represented. International attention also exceeded all expectations. For further information, please contact: Johanna Boijer-Svahnström, Vice President Corporate Communications, johanna.boijer@vikingline.com, +358 18 270 00 Kari Granberg, Project Head, Marine Operations, kari.granberg@vikingline.com, + 358 18 270 00 Christa Grönlund, Communications Manager, Finland, christa.gronlund@vikingline.com, +358 9 123 5242 Eleonora Hansi, Communications Manager, Sweden, eleonora.hansi@vikingline.com, 08-452 41 41 Jonas Åkermark, LNG Marine - Sales and Business Development Manager, AGA Gas ABjonas.akermark@se.aga.com ,+ 46-8-731 18 44  Film in swedish: https://youtu.be/YojYr1pXTpI

New Book By Saab: A Journey Of Change In The Aircraft Industry

During the years 2000 to 2015, Saab systematically and increasingly utilised change management to adapt the company to rapid and fundamental changes. At the same time, the company also worked to ensure its survival in an increasingly globalised and competitive market. Today, Saab is a world-leading manufacturer of advanced fighter aircraft systems and the new book aims to illustrate some important keys to success. “With the Gripen programme Saab has developed a unique capacity to develop, produce and export highly competitive fighter aircraft at the very forefront of technology. With this book we wish to inspire others to initiate and conduct change management, regardless of organisational type“, says Ulf Nilsson, head of Saab business area Aeronautics. The new book was launched at a press event in Linköping on Thursday 25 August. Please click here (http://www.saabaircraftindustry.com) to access the book, which is available digitally only in both English and Swedish. For further information, please contact:Saab Press Centre,+46 (0)734 180 018,presscentre@saabgroup.com www.saabgroup.comwww.saabgroup.com/YouTubeFollow us on twitter: @saab (http://www.saabgroup.com/YouTube) Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Finland’s largest media companies to launch a shared Automated Guaranteed marketplace

Press release 25 August 2016 at 10 a.m. FINLAND’S LARGEST MEDIA COMPANIES TO LAUNCH A SHARED AUTOMATED GUARANTEED MARKETPLACE Ten Finnish media companies (Sanoma Corporation, Alma Media Corporation, Otavamedia Ltd, Aller Media Oy, A-lehdet Oy, MTV Oy, KSF Media Ab, Kaleva365 Oy, Improve Media Oy and Keskisuomalainen Oyj) will launch a shared Automated Guaranteed marketplace in autumn 2016. The marketplace makes it easier and faster for media agencies to plan and buy digital advertising. The marketplace covers desktop, mobile and video advertising products. - It’s great to see Finnish media companies joining forces and launching a shared tool for Automated Guaranteed buying. For quite some time now, there’s been a need for a controlled and fast process for reserving and buying digital advertising. We and other media agencies are eagerly looking forward to using this new tool. It represents a positive step forward that we have been hoping to see, says Antti Kallio, Director of Technology at media agency Dagmar. Digital advertising can be bought in an automated manner either as an Automated Guaranteed transaction or by Real Time Bidding. Buying guaranteed campaigns has been a largely manual process. The Automated Guaranteed solution automates the buying process, thereby significantly reducing the work phases involved in booking campaigns with guaranteed impressions. - Our goal is to make it easier and more efficient to buy media space. Many of the tools are still in the development phase globally, so it is great to see Finnish media companies and agencies promoting progress in automated buying, says Johanna Vartiainen, Director of Digital Ad Operations and Development at Alma Media. - We are pleased to work together to introduce a tool here in Finland that ensures the competitiveness of Finnish media in the digital market, adds Hans Edin, Chief Commercial Officer at Sanoma Media Finland. The media companies have selected Adform A/S, a company that specialises in digital advertising solutions, as their shared system provider. Adform has operated in Finland since 2012 and it provides a comprehensive range of online advertising tools for advertising buyers as well as sellers. Adform’s development resources provide a strong foundation for the development of the new system and its launch in the media market. The shared Automated Guaranteed marketplace will simplify advertising buying processes by making it possible to buy digital advertising products from Finland’s largest media companies through a single tool. The service allows buyers to select suitable media and products, check the availability of impressions, negotiate prices, reserve ad placements and submit campaign materials directly to the publishers’ ad servers. Buyers will also be able to monitor the progress of their campaigns through the service. In 2015, 85 per cent of digital advertising campaigns in Finland were bought with traditional guaranteed impressions. In recent years, digital advertising as a whole has quickly risen to become the largest category of advertising. Investments in digital advertising exceeded the print advertising volume for the first time in the first quarter of 2016. In 2015, digital advertising spending in Finland amounted to MEUR 286.1. For more information, please contact: Alma Media, Johanna Vartiainen, tel. +358 50 514 1952Sanoma Media Finland, Timo Rinne, tel. +358 40 571 3634

SCAN BIDCO A/S SUCCESSFULLY COMPLETES SUBSEQUENT ISSUE OF BONDS

Scan Bidco A/S, the parent company of Scan Global Logistics Holding ApS (“Scan Global Logistics” or the “Group”), has successfully completed a subsequent issue of bonds (the “Subsequent Issue”) under the framework of its maximum USD 250 million senior secured dual-tranche bond loan with ISIN NO0010768062 respectively NO0010768070 (the “Bonds”). Following the Subsequent Issue, the outstanding nominal amount under the Bonds will be USD 100 million and DKK 500 million, respectively. The proceeds from the Subsequent Issue will be used to support the bringing together of Scan Global Logistics and TransGroup, its longstanding partner in the United States and a shareholder of the Group, under common ownership.     The transaction was well received by the market, with participation from institutional and private wealth accounts from throughout the Nordics and Continental Europe. Altogether, approximately 50 investors participated in the oversubscribed issue, which was priced at par. Pareto Securities AB acted as Sole Bookrunner in connection with the bond issue. For more information, please contact:Jesper Nielsen, Group CEO, Scan Global LogisticsTel: +45 3248 0004, email: jnie@scangl.comMarkus Wirenhammar, Head of Debt Capital Markets, Pareto Securities ABTel: +46 70 872 5186, email: mw@paretosec.com  About Scan Global LogisticsScan Global Logistics is a Nordic based full-service global freight forwarding provider with nearly 800 employees working out of 42 offices in 19 countries, specialized in complex logistics solutions. SGL offers customers a wide range of global transportation and logistics supply chain solutions with a complete coverage on air, sea and overland transportation.

JLL Appoints Christian Ulbrich President and CEO; Colin Dyer to Retire

CHICAGO AND LONDON, August 24, 2016 - Jones Lang LaSalle Incorporated (NYSE: JLL) announced today thatChristian Ulbrich, who has held the role of President since June, will now also assume the position of ChiefExecutive Officer, effective October 1, 2016. Ulbrich will succeed Colin Dyer, who will retire from JLL at the end of2016 and step down from the CEO role on September 30, 2016. To ensure a smooth transition, Dyer will continue toguide the company’s data, information and analytics priorities through the end of 2016. He also will remain on theBoard of Directors through the Annual Shareholders Meeting in spring of 2017 and serve as an adviser through2017. As President and CEO, Ulbrich will have overall leadership responsibility for JLL’s strategicdirection and growth. He will report to the Board of Directors, on which he serves as an executivemember. He also will chair the company’s Global Executive Board, the most senior internalmanagement committee, on which he has served for eight years.Ulbrich joined JLL in 2005 as Managing Director of JLL Germany and served as EMEA CEO since2009 before being named President. Under his leadership, JLL prospered in EMEA, outperformingchallenging economic conditions by nearly tripling revenue and adding such services as the Tetris design and fit-outsubsidiary and residential consultancy. Ulbrich’s extensive real estate and finance background before joining JLL includes serving as CEO of the HIH groupof companies headquartered in Hamburg, Germany, and part of M.M. Warburg Bank, and holding various positionswithin German and international banks. He is a member of the Board of Directors of Vonovia SE, Germany’s largestresidential real estate company, and holds a Diplom Kaufmann degree in Business Administration from theUniversity of Hamburg. “Working closely with Christian since he joined JLL, I know firsthand his deep understanding ofglobal real estate dynamics and ability to lead across wide and diverse geographies,” said Dyer.“With his guidance and our strong management team, JLL will continue to grow and prosper.”Under Dyer’s leadership since 2004, JLL’s revenues grew more than five times - to $6 billion -through organic growth, over 80 strategic acquisitions across the globe, and the addition of morethan 100 offices and 30 new countries to its geographic footprint. “The Board of Directors is very grateful for Colin’s extraordinary leadership and service to JLL over the past 12years,” said Sheila Penrose, Chairman of the Board. “He has represented JLL on the global business stage,developed a stellar client base and a strong leadership team, and delivered significant shareholder value. We alsoappreciate his commitment to ensure a smooth and thoughtful transition by remaining engaged with the Board andthe company.” Penrose continued: “The Board has worked with Colin on a comprehensive and robust succession process,culminating in Christian’s selection as CEO. We look forward to Christian’s leadership of JLL’s strategy, operationsand corporate culture, building on a strong company legacy.” Ulbrich said: “Colin’s impact on JLL has been significant. He has steered the evolution into a truly global companyand consistently exemplified JLL’s culture of excellence, ethics and teamwork for employees, clients andshareholders. In my new role, I intend to build on the platform of profitable and resilient growth that we havemaintained in the last 12 years; continue our commitment to integrity, diversity and sustainability; and underscoreour leadership position in the digital revolution.”

RNB launches exclusive e-commerce store in men´s fashion

Man of a kind is an e-commerce concept, which offers a carefully selected product range consisting of international luxury brands with Nordic aesthetics. The product range is supplemented by premium services, such as made-to-measure, style advice and inspiring articles about masculine style and fashion.  “We are proud to be able to offer the market our new e-commerce concept Man of a kind. Featuring a large number of exclusive men’s fashion brands, such as Corneliani, Ermenegildo Zegna, Hugo Boss, Eton, Jil Sander, Kenzo and Paul Smith, as well as supplementary premium services, our offering meets a demand with no comparable competition from other e-commerce players,” says Magnus Håkansson, President and CEO of RNB RETAIL AND BRANDS.  The launch of Man of a kind is a step in the implementation of the Group’s long-term digital strategy and it will become a new business area in RNB RETAIL AND BRANDS with Magnus Håkansson as Chairman and Oscar Åsman as Director of Operations.  “It is important to emphasize that we have long experience of managing store concepts and service offerings with top premium positioning. We are now drawing on that experience as we create a similar offering in a digital store. We are with excitement looking forward to continually developing Man of a kind’s strong customer offering,” says Magnus Håkansson.  The launch will occur on August 25, initially in Sweden. Read more on www.manofakind.se 

Polygiene AB (publ.) Interim Financial Statements 1 January – 30 June 2016

Financial trends in brief Key ratios Apr Apr Jan Jan Rolling 12 mos. Whole year -Jun -Jun -Jun -Jun 2016  2015  2016  2015 Net sales 13.0 10.7 26.4 17.5 60.4 51.5Operating –2.3 0.6 –3.6 0.7 1.3 5.6profit EBIT,MSEKProfit after –2.3 0.6 –3.6 0.7 4.9 9.2tax, MSEKOperating –17.6 5.8 –13.7 3.7 7.3 10.9margin EBIT, %Operating –17.6 5.8 –13.7 3.7 8.1 17.8margin aftertax, %Earnings per –0.13 0.04 –0.20 0.04 0.27 0.55share, SEKCash flows –0.8 –1.1 –3.9 –1.7 19.3 21.5MSEK Q1 profits were impacted by planned increased marketing activities and hiring, plus expenses related to the share listing on Nasdaq First North. Q2 investment in PR and marketing activities increased MSEK 2.4 over the same period the previous year. These investments increased MSEK 4.3 for the first six months of the year. Significant event for the period (April–June) In a new segmentPolygiene took a first step into the personal protective equipment and uniforms for work with the US firm Propper, that now advertises they deliver a new collection of high performance underclothing for users with extremely high demands, such as military and rescue services personnel. New partnership in FootwearConverse Footwear Co., Ltd. (Japan) is the first brand for shoes to introduce the advantages of Polygiene Odor Control Technology to Japanese consumers. This will be through the groundbreaking 2016 Converse Spring/Summer “Whiteplus collection”. The partnership with Converse Footwear (Japan) gives Polygiene a foothold in a new market where odor-free shoes shows significant potential among odor-conscious consumers. Polygiene in partnership with HJC, global manufacturer of motorcycle helmetsHJC, the global leading Korean manufacturer of motorcycle helmets, are introducing helmets with odor control in partnership with Polygiene. Starting in the 2016 spring/ summer season Polygiene will be used in every version of their RPHA 11, one of the company’s most advance models. Our partnership with HJC gives Polygiene a strong presence in the fast growing segment of motorcycle helmets. The respected HJC brand, known for their innovation strength, is the largest provider to the US market, with a strong presence in Europe, too.  Polygiene and White Sierra partnering to deliver odor-free garments for the “outdoor” marketWhite Sierra is a US family business providing clothes for all kinds of outdoor activities for the entire family, including skiing, winter activities, hiking, fishing and other family activities. White Sierra will introduce the advantages of “Polygiene Odor Control Technology” to their garments in their “Trail” and “Travel” collections in spring 2017. New board memberJonas Sjögren, CEO for Discovery Networks Sweden, was elected new member of the Board of Polygiene AB (publ) at the AGM 11 May 2016. Significant events after the period end Share optionsIn 2014, Polygiene issued 6,000 warrants to staff and members of the board which, after recalculation based on the share split implemented in fall 2015, entitle holders to subscription of 1,200.00 in total at a purchase price of SEK 3 per share. As of 19 July 2016, all the warrants in this program where exercised in subscription for shares. After registration of the new shares, the total number of outstanding shares in Polygiene AB will increase from 19,316.000 to 20,516,000 and the share capital will increase from SEK 1,931,600 to 2,051,600. Malmö 25 August, 2016The Board This information is information that Polygiene AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 12.00 CET on August 25, 2016.

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Boston, MA

Colorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series on Saturday, August 27th, 2016. The free clinic features current and former Major League Baseball players who will teach baseball skills, drills and life lessons for approximately 200 local youth. Players attending* include 11-year MLB veteran Darren Bragg, as well as Dennis “Oil Can” Boyd, Kevin Buckley, Dave Fleming, Larry Gowell, Ross Moschitto and Ed Phillips. These seven players combine for 31 seasons, 1381 games and 642 hits in Major League Baseball. The clinic will take place at Jim Rice Field at Ramsay Park, running from 9:00 a.m. to 11:00 a.m., located at 1970 Washington St., Boston, MA 02118. Alumni players will train at stations including pitching, catching, base running and life skills. Registration will begin at 8:30 a.m. and the morning will conclude with an autograph session and baseball giveaways for children in attendance.  To register for this clinic, please visit www.baseballalumni.com. Registration is required. For more information regarding the clinic, please contact Nikki Warner, Director of Communications, at (719) 477-1870, ext. 105 or visit www.baseballalumni.com. *Clinicians subject to change. About The Major League Baseball Players Alumni Association (MLBPAA) MLBPAA was founded in 1982 with the mission of promoting baseball, raising money for charity and protecting the dignity of the game through its Alumni players. The MLBPAA is headquartered in Colorado Springs, CO with a membership of more than 7,600, of which approximately 5,600 are Alumni and active players. Alumni players find the MLBPAA to be a vital tool to become involved in charity and community philanthropy. Follow @MLBPAA for Twitter updates. About Legends for Youth Clinics MLBPAA’s Legends for Youth clinics impact more than 15,000 children each year, allowing them the unique opportunity to interact with and learn from players who have left a lasting impact on the game of baseball. The MLBPAA has reached children across America and internationally in Australia, Canada, Curaçao, the Dominican Republic, Germany, Nicaragua, the United Kingdom and Venezuela, through the Legends for Youth clinic series. To donate to this program, visit baseballalumni.com/donate (http://www.baseballalumni.com/donate). The official hashtag of the Legends for Youth clinic series is #LFYClinic. ###

Zinzino launches new product segment: Zinzino Skin Care

Zinzino AB (publ), one of the world's leading direct sales companies within the health products sector, will now launch Zinzino Skin Care as a completely new product segment. The first product launched under the new banner is Skin Serum – 24 hour youth formula. The launch will take place immediately in August on the US market and will be introduced to Europe in October. Skin Serum has been developed by Zinzino and is produced in Zinzino's own production facility, Faun Pharma located just outside of Oslo in Norway. In the USA, the facial skincare product segment is estimated to report turnover of around USD 5.5 billion in 2016. The European market at least matches that in the US. Skin Serum has become a highly attractive product within the Skin Care segment and Zinzino has identified substantial potential for its new product, which will contribute strongly to the company achieving its growth targets and ensuring customer satisfaction.   Zinzino believes that product development is one of the key success factors for increased growth and expansion. Both new products and the development of existing products represent opportunities for enhanced growth, and July saw us begin sales in 19 new territories, meaning the company is now recording sales throughout the entire EU.  – Thanks to our in-house research and development and the fact that we ourselves produce our products, we can be sure that we maintain an extremely high level of quality from start to finish, while simultaneously keeping production costs as low as possible. We are now represented in 33 countries, with a total population of almost one billion. Our potential market is enormous, and with the products we now have in our portfolio, I have full confidence that we will achieve our goals. Our customers and partners must have faith that there is no let up in our own development and be certain that we are offering the best possible products, says Dag Bergheim Pettersen, CEO of Zinzino.   Zinzino Skin Serum is an active formula which gives skin a youthful appearance. Zinzino Skin Serum moisturises and softens the skin, boosting elasticity and rejuvenation. It eliminates fine lines and reduces wrinkles. The serum has both short-term and long-term beneficial effects and is applied under day and night cream. In addition, Zinzino Skin Serum has a neutral scent meaning that it does not compete with other scented products.  For more information, please contact: Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579Certified Adviser: Erik Penser Bank                         www.zinzino.se The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 25, 2016. Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company's values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health's products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.

Q-Free Open Roads contracted for ATMS Service and Maintenance contract with WVDOH

25 August 2016 Chesapeake, VA— The West Virginia Division of Highways has contracted Q-Free Open Roads, Chesapeake (Q-Free OR), the leading provider of innovative Intelligent Transportation Systems (ITS), for a $1.4 million maintenance contract to maintain and enhance OpenTMS v.8, the WVDOH Advanced Transportation Management System (ATMS). In 2008, Q-Free OR designed and deployed the WVDOH statewide ATMS solution – OpenTMS, the most fully-featured and easy-to-use off-the-shelf ATMS solution on the market, enabling intelligent and automated transportation operations. The collaborative effort between Q-Free OR and WVDOH has resulted in West Virginia becoming a national leader in ITS.  New initiatives since 2008 have included · Statewide 511 Travelers Information System that includes a “Know Before You Go” travelers information web site, www.wv511.org, a cell phone app, “Drive Safe” and an Interactive Voice Response (IVR) telephone system. · Twenty-four 911 CAD Integrations providing “real time” 911 Center highway related incident information to the WVDOH Transportation Management Center (TMC). · Video Analytics System providing 24/7 automatic incident detection, working in the background to assist TMC Operators. · Truck Parking Guidance System supplying the trucking industry information on available truck parking spaces in rest areas. · Automated Incident Management System presenting TMC operators with recommended incident response plans per a “Drools Guvnor ‘Rules Based’ Engine” specifically written to follow WVDOH standard procedures. Q-Free OR is a leading supplier of Intelligent Transportation Systems products and services. The Q-Free Group has approximately 470 employees with offices in 20 countries and presence on all continents. The Q-Free head office is in Trondheim, Norway. Q-Free is listed on Oslo Stock Exchange under the ticker QFR. Further Q-Free information is available at www.q-free.com . Contact Details Q-Free Open Roads, Chesapeake Barbara Skiffington President +1 757-546-3401 bbskiffington@q-free.com Q-Free ASA Roar Østbø CFO +47 932 45 175 roar.ostbo@q-free.com

Burlington financial advisor seeks to boost community sports with award

A financial advisor from Burlington, Ontario, has been nominated for a coaching award and is seeking to use his selection to support youth sports in the local community. Steffen deGraaf has been recognised for working with financial clients during the day and then supporting and mentoring young athletes in the evening and on weekends, and was recently nominated for the AGF/CFL Community Coach of the Year award.  The winner of the award will receive a $5,000 donation from AGF Investments to give to a charity of their choice. This grant is why deGraaf is keen to secure as many votes as possible and he already has a plan in place for the donation that will give back to the local community and support disadvantaged children from the area. Should deGraaf win, the money will be donated to Burlington Minor Football Association (BMFA) to create a special fund to help local youths. The money will be used to help 12 children from financially challenged families participate in sports and be part of the team, covering expenses that their families may otherwise not have been able to pay. Steffen deGraaf, Founder of Infinity Insurance and Investments, said, “Sports creates an opportunity for teamwork and being part of something bigger than yourself. Being part of a team can help give children a purpose and support them in developing a range of skills. Every child should have the opportunity to play a sport they love while making new friends, working towards achievements and being involved in their community. The $5,000 donation will go a long way and could make a huge difference to 12 children.” deGraaf began coaching his own children almost a decade ago, and over the last ten years he has developed his skills through regular Professional Development Clinics, working towards his NCCP Certification in both Baseball and Football here in Canada. After three years coaching soccer he transitioned to baseball and football and in the past season coached both an Atom and PeeWee Football team. The newly created AGF Community Coach of the Year award was just launched in 2016 to recognize financial planners and advisors who volunteer their time to coach an amateur sports team and promote dedication, sportsmanship and teamwork. The nominees have been narrowed down to five finalists across all of Canada and the public can vote until October 15 2016.   To find out more about AGF Community Coach of the Year and vote for Steffen deGraaf visit  http://bit.ly/2bBeWna. Steffen can also be contacted directly by e-email at stef@iiis.ca or by phone at 1-800-303-7196. 

OmniCX Digital Ecommerce Suite Helps Big Brand Names Have A Measurable Impact

OmniCX, the digital ecommerce suite, is helping big brand names have a huge impact at peak trading times, with bespoke solutions that can be changed or enhanced rapidly to meet demand. The essential ecommerce tool, which incorporates the latest technology to ensure customers remain ahead of the competition, has helped The Fragrance Shop to achieve record sales over the busy Christmas period, thanks to a custom-built solution created by the OmniCX team. OmniCX helps businesses create a seamless omni-channel experience for customers across all devices – and it’s this breakthrough that helped The Fragrance Shop post sales increases of 11.8% in the five weeks leading up to 27 December 2015. Multi-channel retailing was the fuel behind this growth, with customers ordering online and using the retailer’s innovative one-hour Click-and-Collect service to ensure they’d chosen a fragrance their loved ones would appreciate. Vikram Saxena, CTO  of OmniCX, says, “We created this unique solution for The Fragrance Shop in the run-up to the peak trading season over Christmas, and the MD of the firm has acknowledged it’s importance in helping them to achieve high levels of growth. It’s this emphasis on multi-channel integration that’s so vital for businesses nowadays – especially at Christmas, when shoppers are increasingly shunning the High Street for their smartphones and tablets, to find the best deals on-the-go. “OmniCX gives companies the ability to change or enhance their ecommerce solutions rapidly, to adapt to the demand their customers are placing upon them. This responsive, seamless process ensures ecommerce businesses are more agile, and primed to meet the needs of their customers without overhauling their whole systems.” The chief executive of The Fragrance Shop, told RetailWeek: “Our Christmas trading figures demonstrate that The Fragrance Shop continues to be First for Fragrance. Our drive for innovation in the fragrance retailing industry has seen us launch a one-hour ‘Click and Collect’ service while expanding our store portfolio. In the multi-channel age, customers still want to try out the fragrance they are buying for a loved one, which is why services like Try It First are proving so popular.” Business owners hoping to try out OmniCX for themselves as invited to attend Ecommerce Expo, which takes place on 28-29 September at Olympia London. OmniCX will be in attendance, with previous satisfied customers speaking at the conference, explaining how the solution has helped them to grow their business. Visitors will also be able to book a demo, to see how OmniCX can help revolutionise their ecommerce offering. For more information, visit the website: www.omnicx.com

Earlier release of Interim Report for January - June 2016

Zinzino hereby announces that the company will present the publication of the interim report for the period of January - June 2016, Friday the 26th of August at 13:00.        For more information, please contact: Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00 For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579 Certified Adviser: Erik Penser Bank www.zinzino.se The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 25, 2016.     Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company’s values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health’s products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.

Kungsleden leases 5,400 sqm in Västerås

Västerås is Sweden's fifth largest city and an important growth and logistics area whose attractiveness constantly increases, partly thanks to extensive infrastructure investments. Kungsleden owns 525,000 sqm, in the city, of which 153,000 sqm in the cluster Västerås City and 236,000 sqm in Finnslätten industrial park. The Migration Agecny is already leasing premises in the property Ottar 5 (the so called Melker building), but the operations are expanding and when the agency now needs more office space, Kungsleden was able to offer additional premises in the neighboring property Ottar 6 (the so called Nore building). Myndigheten lämnar nu 1 679 kvm i Ottar 5 och hyr från och med årsskiftet 2 538 kvm i Ottar 6 och 493 kvm i Ottar 5. ”It was important for us to find larger suitable premises at the right price without having to move so far. Therefore, we were very pleased that Kungsleden could offer us more space in the Nore building”, says Jonas Haglund at the Migration Agency.  ”We are very happy to be able to offer these nice premises within our city cluster to the Migration Agency that has been our customer for many years. The property Ottar 6 is a centrally located brick building were the Migration Agency will get a highly visible entrance towards the Asea square”, says Mats Eriksson, Regional Manager Mälardalen, Kungsleden. Kungsleden has also signed an agreement with Mälarenergi’s subsidiary Fibra AB to lease premises in the block Mimer 5, also in the cluster Väasterås City. Fibra leases 1,200 sqm as of October 1, 2016. In the Tegnér area, the property Isolatorn, ABB will lease an additional space of 1,172 sqm. ABB will get access to the new space on September 1, 2016. Photo: Ottar 6 

Continued strong growth and improved EBIT margin

· Net sales increased 21% to MSEK 159.1 (131.6). · EBIT rose 33% to MSEK 18.5 (13.9). · EBIT margin amounted to 11.6% (10.6). · Net income was MSEK 15.4 (9.7). · Earnings per share amounted to MSEK 1.54 (0.97). Stefan Jonsson, President and CEO:GARO performed strongly in many respects. The Group’s net sales increased 21% in the second quarter with sustained strong growth in Sweden and Other markets. The EBIT margin improved, thus contributing to a 33% increase in EBIT, and was mainly the result of volume growth combined with stable expenses, generating economies of scale.Net sales for GARO Sweden rose 17%, with significant increases in all product areas. The construction market remained strong with backlog demand for new apartments and single family homes. With GARO’s broad product range, this trend benefits our product areas of Electrical distribution products, Project business and Temporary electric installations. It is also gratifying to see that EV charging continues to grow strongly.Net sales for GARO Other markets rose 28%, with a strong increase primarily in EV charging in Norway, where we consolidated our leading position. Temporary electric installations also reported a satisfactory trend and it was gratifying that this product area performed so well in Finland. In Ireland, Electrical distribution products continued to follow the strong performance of the construction market.Gnosjö, 26 August, 2016  For more information, please contact:Stefan Jonsson, President and CEO: +46 70 588 66 73Lars Kvarnsund, CFO: +46 070 516 59 98Patrik Linzenbold, IR Director: +46 708 25 26 30  This information is such information that GARO aktiebolag is obligated to publish in accordance with the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was published by the abovementioned contact persons on August 26, 2016, at 7:30 a.m. GARO develops, manufactures and supplies innovative products and systems for the electrical installations industry under its own brand. The company has operations in Sweden, Norway, Finland, Ireland and Poland and the Group is organized in two business segments GARO Sweden and GARO Other markets. GARO has a broad product assortment and is a market leader within several product areas. The Group has sales of about MSEK 600 and has approximately 260 employees. Its head office is located in Gnosjö.The business concept is “with simplicity and design, GARO provides the smartest and most profitable solutions – fitted into systems.” 

Interim report January - June 2016

SUMMARY FOR THE SECOND QUARTER, 1 April - 30 June 2016 1) ● Revenue increased 3 per cent to SEK 1,573 M (1,527). Excluding the acquisition of Opus Equipment, revenue rose 1 per cent. Adjusted for currency effects and calculated on the comparable number of workdays, revenue increased 3 per cent. Sales in comparable units rose 6 per cent.● EBITA amounted to SEK 189 M (224) and the EBITA margin amounted to 12 per cent (15).● EBIT amounted to SEK 161 M (197) and the EBIT margin amounted to 10 per cent (13). MECA’s export business to Denmark had a negative impact of SEK 4 M (neg: 10) on EBIT. EBIT was negatively impacted by non-recurring effects of SEK 9 M (neg: 1), of which SEK 7 M (0) impacted the gross margin.● The gross margin amounted to 53.6 per cent (54.7).● Earnings per share, before and after dilution, amounted to SEK 3.02 (3.74).● Cash flow from operating activities rose to SEK 228 M (137), of which discontinued operations comprised a negative SEK 2 (neg: 45).● Net debt at the end of the period amounted to SEK 1,684 M (1,841), compared with SEK 1,626 M at year-end. 1) During the first quarter of 2015, the last two stores in Denmark were discontinued and the Danish store operations are presented in the 2015-2016 interim reports according to the rules on discontinued operations in IFRS 5. The Danish store operations were previously included in the MECA segment. With the exception of cash flow and net debt, all amounts pertain to continuing operations. CEO’s comments The Group continued to grow but the result was burdened by Mekonomen Sweden The result in the second quarter did not meet our expectations, mainly due to weak profitability in Mekonomen, while MECA and Sørensen og Balchen had a good development in the period. During a period characterised by reorganisation and system changes, Mekonomen Sweden lost revenue and market share and reported a weak gross margin. A package of measures is launched to increase sales and reduce costs. The weakened NOK has also contributed to negative effect on the Group’s profit in the quarter. EBIT for the quarter was SEK 161 M, compared with SEK 197 M in the second quarter 2015.We see potential for a growing overall market. For Mekonomen Group, the main potential for a stronger market is linked to a growing fleet of cars aged three years and older when the cars enter and become part of our core business model. The growing fleet of cars and completion of changes initiated in Mekonomen Group, particularly those linked to the Swedish operations and the announced group-wide structure projects, provide a solid platform for future profitable growth. Favourable underlying growthMekonomen Group’s total sales rose 3 per cent in the second quarter. Sales in comparable units increased 6 per cent, primarily driven by sales to affiliated workshops. The sales development was particularly strong in MECA’s Swedish and Norwegian operations. Sales of spare parts from our proprietary brand ProMeister continued to perform positively during the quarter.Mekonomen Sweden affected by organisational changesThe work with the organisational change and the new store data system, initiated at the end of 2015, has not produced the desired effect. This work has taken much energy and negatively impacted sales, resulting in Mekonomen Sweden reporting negative underlying sales growth for the quarter. Now we take powerful action to deal with the changes that we want to implement. We are convinced that the new working methods of increased local responsibility and presence among customers is the right model for the future with the aim to increase the sales. In parallel with the completion of the organisational change, we also implement an efficiency and cost-rationalisation program for Mekonomen Sweden which is expected to generate annual savings of SEK 25 M from 2017. The cost of the program is expected to have only a marginal impact on EBIT for 2016. Reduced loss in DenmarkOur focus to cost efficiently driving increased sales in Denmark continued and the loss in the second quarter fell to SEK 4 M. The loss has more than halved since year-end 2015 but it is never satisfying with a loss and we are working impatiently ahead with turning the business. Focus on profitable growth and innovationIn the second half of 2016 is the growth continued our most important focus area and we see the greatest potential for increased sales in our core business with workshops and other B2B customers. Prioritised is also the implementation of the saving program in Mekonomen Sweden and in longer term the efficiencies to be achieved with the new central warehouse structure.In Sweden, personal car leasing have had a strong development and the automotive industry itself believes that the proportion of personal leased cars, as part of new car sales, can be as much as 50 per cent by end of the year. Thus, Mekonomen Group chooses becoming the first player in our industry from the independent side to launch our own offer directly to end users, Mekonomen Car Leasing.I have great reliance to Mekonomen Group is on track with the ongoing change process and in combination with favourable market conditions going forward, I am confident about the future.Magnus Johansson President and CEO For further information, please contact:Magnus Johansson, President and CEO, Mekonomen AB, tel: +46 (0)8-464 00 00Per Hedblom, CFO Mekonomen AB, tel: +46 (0)8-464 00 00 This information is information that Mekonomen AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 a.m CET on 26 August 2016.

Ferronordic Machines - Changes in management

Erik Eberhardson, founder and head of business development, has expressed a wish to reduce his operational engagement in the company in order to take part also in other business activities. Mr. Eberhardson will therefore cede his role as head of business development and will no longer be part of Ferronordic Machines’ executive management. However, Mr. Eberhardson will continue to support the development of the company in his role as vice chairman of the Board, in particular with regard to long-term strategy and contacts with certain important business partners. Mr. Eberhardson also remains one of the largest shareholders in Ferronordic Machines. ---------------------------------------------------------------------------------------  About Ferronordic Machines Ferronordic Machines is the authorized dealer of Volvo Construction Equipment and Terex Trucks in Russia. It is also the official Russian distributor of Dressta. In certain regions of Russia, Ferronordic Machines has also been appointed aftermarket dealer for Volvo and Renault Trucks and dealer for Volvo Penta. Ferronordic Machines began its operations in 2010 and has since then expanded rapidly across Russia. The company is well established in all federal districts with almost 70 outlets and approximately 750 employees. The vision of Ferronordic Machines is to be regarded as the leading service- and sales company in the CIS markets. The preference shares of Ferronordic Machines are listed on NASDAQ OMX First North Premier. The company has appointed Avanza Bank AB as its Certified Advisor. www.ferronordic.com For more information, please contact: Anders Blomqvist, CFO and Head of IR, Tel: +46 8 5090 7280 or pr@ferronordic.com Ferronordic Machines discloses the information herein pursuant to the Securities Markets Act and/or the Financial Instruments Act. The information was submitted for publication on 26 August 2016, 07:45 CET. 

CXENSE ASA ANNOUNCES SECOND QUARTER RESULTS - Q2 2016

OSLO, NORWAY - AUGUST 26, 2016 - CXENSE ASA TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER, WHICH ENDED JUNE 30, 2016.Highlights:- Q2 2016 revenues of USD 6.3 million, up 79% vs. Q2 2015, and New Annualized Recurring Revenue (ARR) closed in Q2 2016 of USD 2.6 million – 59% above the average of the last three quarters. - Strong new customer wins such as Aller Media AS and Japanese fashion retailer Nissen Co. Ltd, and significant upsell to existing client The Wall Street Journal. - Q2 2016 lost ARR (churn) was USD 1.4 million, due to higher than expected churn on legacy Maxifier software. Churn is expected to normalize in the following quarters. - Q2 2016 EBITDA of USD -1.3 million, a significant improvement from USD -3.1 million in Q2 2015. - Three new leading investors, Aker ASA, Charles Street International and Ferd AS, invested USD 19 million in new equity, enabling Cxense to faster pursue organic and acquired growth. - Accelerated sales growth is expected to move the EBITDA break-even point beyond 2016. - Cxense transferred to the Oslo Børs’ main list from Oslo Axess on 12 August 2016. “Cxense experiences increasing demand for its leading personalization and data management software and we successfully signed new customers and increased our engagement with existing ones in Q2 2016. Churn affecting ad solutions was disappointing, but is expected to move down in coming quarters. We have successfully strengthened our financial position, shareholder base and investor reach by raising new equity and listing on the Oslo Børs. We are now in position to invest in growth and take Cxense to the next level.”, says Ståle Bjørnstad, CEO of Cxense ASA The Q2 2016 report and presentation are attached to this notice. Cxense ASA is presenting its Q2 2016 results on Friday August 26, 2016, at 08:30 am CET. The presentation will take place at the Felix Conference Center, Bryggetorget 3,Oslo, Norway.  A live webcast will be available at:http://webtv.hegnar.no/presentation.php?webcastId=36208086  About CxenseCxense (pronounced "see-sense") enables the world's leading media, e-commerce and consumer brands to take control of their audience data to deliver more engaging and personalized user experiences. Businesses using Cxense's advanced real-time analytics, data management (DMP), advertising, search and personalization technology gain more engaged users, increased digital revenue and higher sales conversions. Cxense is headquartered in  Oslo, Norway, with offices worldwide.  Customers include the Wall Street Journal, USA Today (Gannett), Grupo Clarin, El Pais, Bonnier, Naspers, Ebay, The Golf Channel, PGA, NBA, NFL, ABC News, FOX Sports, Singapore Press Holdings, South China Morning Post, AEON, DMM, Rakuten and many more. For more information: www.cxense.com, Twitter: @Cxense. Cxense is listed on the Oslo Stock Exchange with the ticker 'CXENSE.'Investor Relations Contact:Jørgen Loeng, Chief Financial OfficerEmail: jorgen.loeng@cxense.comMobile: +47 906 60 062

Stefan Backman appointed Group General Counsel and new member of Tele2 AB’s Leadership Team

Stefan Backman replaces Caroline Fellenius-Omnell, who will assume the position of Executive Vice President Group General Counsel at Skanska Group. Stefan has a long and extensive background in telecoms, with experience from both legal and regulatory fields. He joined Tele2 in 2007 and has been pivotal in Tele2 Sweden's growth, particularly with respect to corporate development, governmental relations, regulatory affairs, corporate governance and most recently in the leadership of the network JVs. Stefan has a degree in Law from the University of Uppsala. Before being appointed to Group General Counsel, Stefan held the position of Head of Legal, Regulatory & Network at Tele2 Sweden. Allison Kirkby, President and CEO of Tele2 AB, comments: ”Stefan will contribute immediately and brings extensive commercial and legal experience from his years within Tele2, and from his professional training. I am extremely proud to be able to promote such a great individual from within our Tele2 talent pool, proving again Tele2's bench strength. Caroline has done a great job heading up our Group Legal and Regulatory team during a period of significant change, and I wish her every success in her new role.” Stefan Backman, incoming EVP Group General Counsel at Tele2 AB, comments: ”I am thrilled to accept this position and look forward to stepping up to the Group Leadership team, and supporting Tele2 as it pursues its responsible challenger strategy.” Caroline Fellenius-Omnell, resigning Group General Counsel at Tele2 AB, comments: “I have had a fantastic time at Tele2 and I want to thank all my colleagues for their dedication and hard work during these years. I am now looking forward to pursuing my new role at Skanska Group.” For more information, please contact:Viktor Wallström, Communications Director, Tele2 AB, Phone: +46 703 63 53 27Louise Tjeder, Head of Investor Relations, Tele2 AB, Phone: +46 704 26 46 52 This information is information that Tele2 AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the Director of Communications set out above, at 08:00am CEST on August 26, 2016. TELE2 IS ONE OF EUROPE'S FASTEST GROWING TELECOM OPERATORS, ALWAYS PROVIDING CUSTOMERS WITH WHAT THEY NEED FOR LESS. We have 16 million customers in 9 countries. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2015, we had net sales of SEK 27 billion and reported an operating profit (EBITDA) of SEK 5.8 billion. For definitions of measures, please see the last page of the Annual report 2015.

Boule Diagnostics awarded contract in USA

Via its US subsidiary, Boule Diagnostics has signed an agreement with Novant Health Systems in the United States, as the primary vendor for three part differential hematology systems. Novant Health System is a highly reputable not-for-profit integrated network of physician clinics, outpatient centers and hospitals in the states of North Carolina, Virginia, South Carolina and Georgia. Novant Health Systems has a total of 15 hospitals and more than 530 doctor’s clinics. Boule estimates that the agreement covers approximately forty hematology systems, including equipment, consumables, service and support through December 31, 2019. Instruments will start to be delivered at the end of the year. "This agreement strengthens our position on the US market, which is great news for Boule as the US is the world’s largest market by value and where quality and performance really count. We feel this has been instrumental in our being chosen as a supplier, particularly as our systems were not the lowest priced systems. Further proof that our focus on products in the premium segment is spot on,” says Ernst Westman, President and CEO, Boule Diagnostics. For more information, please contact:Ernst Westman, CEO and president, Boule Diagnostics AB, tel +46 708-60 88 63  About Boule Diagnostics AB Boule Diagnostics AB is a fast-growing diagnostics company, developing and manufacturing systems and consumables for hematology diagnostics for the public healthcare providers worldwide. The company is primarily focused on small and medium-sized hospitals, clinics and laboratories in outpatient care as well as other diagnostics companies in both human and veterinary hematology. The group is comprised of operating subsidiaries in Sweden, the US and China. The Boule Diagnostics share is traded on NASDAQ Nordic since 2011. www.boule.se  The information in this press release is such that Boule Diagnostics AB must disclose it in accordance with the Securities Market Act and/or the Financial Instruments Trading. The information was submitted for publication in Swedish at 8:45 am (CET), August 26, 2016.

Bravida strengthens operations in Småland by acquiring OCM Vent

– This acquisition marks our return on the HVAC market in Småland, but it will also further strengthen our HVAC operations in Gothenburg, says Anders Ahlquist, Division Manager, Bravida Division South. The main part of OCM Vent’s operations is HVAC installation contracts, but there are also a great deal of service assignments. Among the customers are industries, retailers, private property owners and building companies. – The firm has had a strong growth lately and we felt that the next step for continued development was to enter a larger organisation. We have built our operations on long-term customer relationships. To us, it was important to sell to a company that shares our values, says Ola Knutsson, CEO of OCM. Åke Forsberg, Regional Manager for Bravida in Region Jönköping, is looking forward to supplementing Bravida’s offering in the area. – Finally! We have been without HVAC operations in Småland for some years now, and it feels great to be able to offer the complete set again – electrics, heating and plumbing and HVAC. For us, this acquisition will be the hub of continued development of our HVAC offering in our region, says Åke Forsberg. Bravida takes over the operations on 1 October 2016. For further information, please contact:Anders Ahlquist, Head of Division, Bravida Division South. Phone: +46 31-709 52 58Ola Knutsson, CEO, OCM Vent. Phone: +46 768-314 100Åke Forsberg, Regional Manager, Region Jönköping. Phone: +46 705-56 80 40Anders Bådholm, Regional Manager, Region Göteborg. Phone: +46 31-709 52 26

New Study: Swedish Nevisense can reduce follow-up visits by half for difficult-to-diagnose lesions in melanoma detection

Malignant melanoma is often difficult to detect, and early detection is of crucial importance. Lesions suspected of being malignant melanoma, but which cannot be clearly determined during the initial examination, are followed up in many cases with the help of what is known as short term digital dermoscopy imaging (SDDI), which means that the lesion is photographed and compared over time.  The use of SDDI is increasing – especially in difficult-to-diagnose cases – but it is resource-intensive and can take three months or more for a final diagnosis. In addition, it can be challenging to get patients to return for follow-up visits. In the new Australian study, conducted by Dr Lilian Rocha, Associate Prof. Pascale Guitera, Prof. Scott W. Menzies et. al. at the Melanoma Institute of Australia and Royal Prince Alfred Hospital in Sydney, SDDI was combined with Nevisense’s  electrical impedance spectroscopy (EIS) measurement with the following results: · 19% of all examined lesions showed a Nevisense EIS value of seven or more and were surgically removed immediately. 83.1% of the malignant melanoma in the study was discovered by Nevisense three months earlier than what SDDI would have allowed. · 28% showed a Nevisense EIS value of three or less, which would have made the need for a patient follow-up visit unnecessary. · The combination of SDDI and Nevisense detected 100% of all malignant melanoma in the study. In total, the use of Nevisense showed the potential to reduce the number of cases that needed to undergo SDDI by 47%. This could simplify diagnostics and lead to significant cost savings for health care while shortening patients’ waiting time for a diagnosis.  “The cases in the study involve difficult-to-diagnose lesions, and the current diagnostic process is time consuming for both clinicians and patients. This study result is very important because it shows the potential for Nevisense to improve the process - saving both time and resources in the healthcare sector” says Simon Grant, CEO at SciBase. For more information, please contact:Simon Grant, CEOPhone: +46 72 887 43 99Email: simon.grant@scibase.com This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10.00 CET on August 26, 2016. About Skin CancerSkin cancer is one of the most common cancers in the world, accounting for nearly half of all cancers. It has been estimated that nearly half of all Americans who live to the age of 65 will develop skin cancer at least once. Malignant melanoma is the most fatal form of skin cancer causing the majority (75%) of deaths related to skin cancer. Worldwide, doctors diagnose about 230,000 new cases of melanoma yearly. About SciBase and NevisenseSciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed a unique point-of-care device for the accurate detection of malignant melanoma. Its product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. SciBase was founded by Stig Ollmar, Associate Professor at The Karolinska Institute in Stockholm, Sweden. Nevisense is based on substantial research and has achieved excellent results in the largest clinical study ever conducted on the detection of malignant melanoma. Nevisense is CE marked in Europe, has TGA approval in Australia, and is awaiting FDA clearance in the United States. Nevisense is based on a method called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human tissue to categorize cellular structures and thereby detect malignancies. SciBase is listed on Nasdaq First North (“SCIB”). Avanza is the certified advisor. Further information is available on www.scibase.com. 

Håkan Kirstein appointed as Eltel’s new CEO

Håkan Kirstein is currently a member of the Board of Directors at Eltel AB, which he joined in May 2016. He started his career in the retail business at Statoil and progressed to being CEO of Statoil Hydro Sweden AB. He spent 15 years at Statoil. Following the period at Statoil, Mr Kirstein held the position as CEO of Niscayah Group AB, a market leader in the technical security services and at that time listed on Nasdaq Stockholm. Under his leadership the company underwent a major transformation programme resulting in a significant profitability improvement. Prior to joining Eltel’s board, Håkan had an interim assignment as CEO of Imtech Nordic AB, a leading installation company in electrical engineering, heating and sanitation and HVAC technology. Eltel’s chairman of the Board of Directors Gérard Mohr comments: "Håkan Kirstein has a solid track record in the management of service business with high customer oriented focus and proven leadership skills in decentralised and multi-site companies, which fits well with The Eltel Way. He is also experienced in operations where excellence in project management is key. In addition, the Board was impressed by his strategic strength during his involvement in Eltel’s strategy review process in the first half of this year. I am confident that Håkan has excellent prerequisites to be successful in leading the future development of Eltel.” Håkan Kirstein comments: "I am honoured to have been appointed the CEO of Eltel. It is a privilege to be part of a company fiercely committed to delivering high quality service and solutions to our customers. I genuinely look forward to become part of the Eltel team”. As of 19 September Mr Kirstein will leave his position as member of the Board of Eltel and Mr Kirstein’s board position will currently not be replaced by a new member. Eltel’s Board of Directors and Axel Hjärne have agreed that Axel Hjärne will stay on in his position as CEO until 18 September 2016. “Under Axel Hjärne’s outstanding leadership, and thanks to his vision and his shaping of “The Eltel Way”, Eltel has grown to rank among the European leaders in the Infranet industry. On behalf of the whole Board, I thank Axel for his great contribution", says Gérard Mohr. For further information:Ingela UlfvesVP – IR and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com   This information is information that Eltel AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 12.00 CET on August 26, 2016. About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2015 Eltel net sales amounted to EUR 1,255 million. The current number of employees is approximately 9,600. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Interim Report for 1st January - 30th June 2016 Zinzino AB

” In July Zinzino launched their business in 19 new countries in Europe. This means that including the EU countries we are present in 33 countries in total in the world. That provides us a potential market with close to 1 billion people. During the second quarter we have launched new products and invested in a future in which we have a strong believe in. We will hold on to our ambitious goal to grow at least 20 percent in the coming 3 years and improve results every year. ” Dag Bergheim Pettersen, vd, Zinzino AB  SECOND QUARTER 2016 (COMPARED TO SAME TIME PERIOD LAST YEAR, 2015) · Total revenues amounted to SEK 109.1 (112.2) million which corresponds to a sales decline of 3% (+ 41%).  · The product segment Health increased by 4% to SEK 74.5 (71.6) million, which represented 68% (64%) of the total revenue for the quarter. The product segment Coffee amounted to SEK 15.3 (20.9) million which represented 14% (18%) of total revenue and a sales decline of 27%. Faun Pharma and other revenues amounted to SEK 19.2 (19.7) million representing the remaining 18% (18%) of total revenue.  · Gross profit amounted to SEK 35.8 (33.8) million and the gross profit margin amounted to 32.8% (30.1%).  · EBITDA amounted to SEK 4.6 (7.8) million and the operating margin before depreciation and amortisation to 4.2% (6.9%).  · Depreciation and amortisation amounted to SEK 2.2 (2.2) million, of which SEK 1.2 (1.4) million was attributable to depreciation of goodwill.  · Operating profit amounted to SEK 2.3 (5.6) million and the operating margin was 2.1% (5.0%).  · Profit before tax amounted to SEK 2.3 (5.2) million.  · Net earnings per share after tax (fully diluted) amounted to SEK 0.03 (0.12)  · The Annual Meeting of Shareholders adopted a dividend of SEK 0.25 (0.25) per share and in total distributed SEK 7.8 (7.7) million to shareholders.  CUMULATIVE JANUARI - JUNE 2016 (COMPARED TO SAME TIME PERIOD LAST YEAR, 2015) · Total revenues amounted to SEK 221.7 (221.2) million which corresponds to a sales increase of 0% (+43%).  · Zinzino Health increased by 10% to SEK 151.1 (137.6) million, which represented 68% (62%) of total revenue. Zinzino Coffee amounted to SEK 30.8 (42.4), which represented 14% (19%) of total revenue and a revenue decline of 27%. Faun Pharma and other revenues amounted to SEK 39.8 (41.2) million which represented the remaining 18% (19%) of total revenue.  · Gross profit amounted to SEK 76.8 (70.6) million and the gross profit margin amounted to 34.7% (31.9%).  · EBITDA amounted to SEK 12.8 (16.7) million and the operating margin before depreciation and amortisation to 5.8% (7.5%).  · Depreciation and amortisation amounted to SEK 4.5 (4.2) million, of which SEK 2.5 (3.0) million was attributable to depreciation of goodwill.  · Operating profit amounted to SEK 8.3 (12.5) million and the operating margin was 3.7% (5.6%).  · Profit before tax amounted to SEK 8.0 (11.7) million.  · Profit after tax amounted to SEK 5.2 (9.3) million.  · Net earnings per share after tax (full dilution) amounted to SEK 0.15 (0.28)  · Liquid assets amounted at the report date to SEK 24.0 (38.6) million.  SIGNIFICANT EVENTS DURING AND AFTER THE SECOND QUARTER OF 2016 · Through a new export initiative in the Swedish subsidiary Zinzino Sverige AB, Zinzino in early July commenced sales in the remaining, previously non-established markets in the EU such as Great Britain and Spain. The establishment model is simple and rapidly expansible with increased volumes. It is also very cost-effective to implement. If the investment turns out well it may generate substantial revenues for the company in the years ahead.  · Towards the end of the second quarter, Zinzino launched an entirely new product in Zinzino Health – BalanceOil AquaX. This is a further development of Zinzino’s BalanceOil to which has been added a unique emulsifying substance, Aquacelle. With BalanceOil AquaX the Omega-6/Omega-3 concept is taken to a whole new level.  · The product was developed through the Zinzino’s research company BioActive Foods together with the production unit Faun Pharma. This has led to the product development having been very fast and cost-effective.  · The Annual Meeting of Shareholders adopted a dividend to the shareholders. The Annual Meeting of Shareholders decided dividend to the shareholders of SEK 0.25 per share, which resulted in a total of SEK 7.8 million being distributed to the shareholders for the previous fiscal year. The current Board of Directors was re-elected for an additional year. · The subsidiary Faun Pharma AS signed a supply agreement with ProteinfabrikkenZinzino’s production plant Faun Pharma AS, during the second quarter, signed an important agreement with the key Norwegian customer Proteinfabrikken , this means an increase of Faun’s production by 500-600 tonnes per year. The agreement was signed for three years with an expected total value of more than NOK 30 million in increased sales during the period. Production was started during the summer and is estimated to amount to fully NOK 20 million for the rest of 2016, substantially more than had been expected.  · Internal efficiency improvements cut costs and reduced delivery timesDuring the quarter Zinzino has done further work to increase the efficiency of its operations. For this reason Zinzino is changing its collaboration partner as relates to billing, reminders and collections. This, combined with further development of the business system will result in cost savings of about SEK 1 million per year.  · Delivery of Zinzino Skin Serum - a new segment in Zinzino’s product range. Zinzino Skin Serum is the first product in the new product segment Skin Care and will be launched initially only on the American market. Launch on other markets is expected to happen in the autumn.  · Zinzino Skin Serum is developed by the company’s own researchers and reduces wrinkles and fine lines which are commonly associated with aging.  COMMENT BY DAG BERGHEIM PETTERSEN, CEO: We expand our business activity to the complete EU areaIn July Zinzino launched their business in 19 new countries in Europe. This means that including the EU countries we are present in 33 countries in total in the world. That provides us a potential market with close to 1 billion people. During the second quarter we have launched new products and invested in a future in which we have a strong believe in. We will hold on to our ambitious goal to grow at least 20 per- cent in the coming 3 years and improve results every year.  Second quarterDuring the second quarter we have fulfilled different strategic projects and investments. We have reached a big milestone in launching our business in 19 new markets in the EU. We launched a new future-oriented web shop with a new design. Within the segment Health we have launched a new product – AquaX – a BalanceOil that can be mixed with water. We launched new price structures and put more time and resources in design, layout and marketing. All these improvements are important for increasing the strength of our brand and create long term growth. By doing the investments necessary we feel that we have put a foundation to come closer to our goal in the coming year.  We are in line with the budget for this year and are relatively satisfied with the quarter although we still have not reached growth in comparison with the last year.Within Health we had a growth of 4 percent during the quarter but within the Coffee a decrease of 27 percent. We have bad margins on the coffee and therefor have to budget a decreasing on coffee with continuous higher focus on products within Health that have a bigger margin. We believe in a growth in the coming 6 months and have focus on improving the margins.  We improved our gross margins up till 32,8 percent, which is 2,7 percent better than as to the second quarter of 2015. Better margins proves that we are doing the right thing when we choose to invest in our business, open markets and continue to develop our own products and focus on people in Zinzino.  New IT-systemAs communicated before, during the last 12 months we have done huge investments in a new IT-system that can handle our growth and the geographic expansion that we planned. This is also an IT-system that can support us in our ambitious goal to have 1 million customers in 2020 and decrease costs for the next coming years. We faced challenges implementing the system which delayed our growth. We feel secure now with our IT-system and see that workflow is more effective, better and simple – that is something that makes us optimistic for the coming years.  Expansion planAs said before, we picked up the pace of our geographic expansion and opened 19 whole new markets. The new markets started up in an effective way and now we are active in 33 countries with almost 1 billion people. Wewill use the next 2 years to work in this market and at the same time planning the next step. After 4 years of hard work with market approach we see now that USA starts to give results. I believe that USA will be our biggest market within 2-4 years and will be leading for our company. USA is the world’s biggest Direct Selling market and we are appealing to partners because we have business model that is very customer focused.Germany established in the first quarter and is the biggest Direct Selling market in Europe. This is a powerful purchasing market, with the focus on health, we have of course high expectations for this market and we already see positive results of being present in the market.  Product developmentThe last 18 months we have actively worked on our product development and thanks to that we could launch our new products. Now we pick up the pace even more and we will launch several strong product concepts during 2016. I see product development one of the deciding factors for success for us and that is why I am proud over the fact that we, thanks to our own research and factory, we can always be one step ahead. New products make us an appealing company for our customers and distributors. With pleasure I can announce that we launched self-developed Skin Serum and even BalanceOil AquaX that we expect will bring us a lot of new customers and attract new partners. Skin Serum has an enormous big market potential and I believe this is going to be a big segment for us in the next coming years. BalanceOil AquaX will be a key product in our biggest product segment Health.  Ambitious GoalWe still have a huge believe in our ambitious goal to have a growth of at least 20 percent in the next three years and improving the results every year. We have a vision that we can inspire a change in life for our customers and partners. We will do this by being the most customer friendly Direct Selling company in the world. To confirm this we even communicated earlier that we will do this by having a million customers by the year 2020.We aspire to inspire!  Dag Bergheim Pettersen, vd, Zinzino AB  For a full report, please see the attached PDF.  INFORMATION ABOUT THE COMPANY: Zinzino was founded under the name Zinzino Holding in autumn 2007. In 2009, the company acquired 93% of the equity and 97% of the votes in Zinzino Nordic AB, partly by means of a non-cash issue and partly by means of a private placement. Zinzino Nordic is a sales company that uses independent distributors to market and sell products for commission via so-called direct sales.  NEXT REPORT: Interim report Q3 2016 will be published on 15 November 2016  For more information, please contact:Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579Certified Adviser: Erik Penser Bankwww.zinzino.se  The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 26, 2016.    Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company’s values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health’s products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the French Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.

ESS Data Management and Software Centre Opens in Copenhagen

"It makes me extremely proud to be the Minister for Higher Education and Science, when I see this amazing international knowledge hub -  ESS’ Data Management and Software Centre - being built in Copenhagen," says Ulla  Tørnæs. "It also makes me proud as a European to see ESS being built together, across borders, in Europe."  The new European research facility is expected to be the world's leading research facility using neutrons and is one of the highest priority research infrastructure projects in Europe. ESS is being built in Lund, Sweden, but will store and process the data it produces at DMSC in Denmark.   The data centre's new offices are located in the Copenhagen Bio Science building, on the north campus of the University of Copenhagen. During the current construction phase the DMSC staff consists of 22 employees developing software and hardware for the control, analysis, and visualization of the experiments to be carried out at ESS. They are working in collaboration with partners at universities and research laboratories all over Europe. When ESS goes into operations the data centre expects to have 60-70 employees. "The DMSC will provide the analysis and modelling software that will help the users of ESS turn data into scientific results and innovation,” says Mark Hagen, Head of DMSC and an experienced neutron scientist who has worked at most of the world's other leading neutron sources. "We are already very active in providing data analysis software for neutron scattering, collaborating on projects with our partners in the UK, France, Germany, USA and, of course, Denmark." The ESS user programme begins and opens for scientifc research in 2023. When that happens, it is expected to produce 3-5 petabytes (PB) of data per year, rising to 7-11 PB over the following years. The data will be transferred between ESS and DMSC through a dedicated fibre connection over the Oresund. "The DMSC in Copenhagen confirms the important role of Denmark as a host country for ESS," says Andreas Schreyer, ESS Director for Science. "The DMSC is a vital part of ESS which will provide new and unprecedented possibilities for the researchers to generate novel scientific results from the data generated in the experiments at ESS." ESS will be up to a 100 times brighter than any similar research facility and will enable scientists an unprecedented capability to probe matter with neutrons on atomic and molecular level. The research at ESS is expected to lead to many discoveries in scientific fields such as life science, energy and new materials.

BLOCK TRADE IN THE MARKETING GROUP PLC

Stockholm, August 29, 2016 – On August 1, 2016, chairman Jeremy Harbour acquired 170,016 ordinary shares and director Callum Laing acquired 170,015 ordinary shares in The Marketing Group in a block trade with an agreed price per share of 6.47 Euros. After the transaction, Jeremy’s holdings in The Marketing Group including direct and indirect as well as through entities he either has a shareholding in or discharges managerial responsibilities amounts to 12.74 per cent and Callum’s holding in The Marketing Group Group including direct and indirect as well as through entities he either has a shareholding in or discharges managerial responsibilities amounts to 5.42 per cent. For more information, please contact Hannah Middleton, Director and Communications Director Phone: +65 8193 7625 E-mail: hannah.middleton@marketinggroupplc.com  Jeremy Harbour, Executive ChairmanPhone: +65 8661 1776 E-mail: jeremy.harbour@marketinggroupplc.com The Marketing Group in brief The Marketing Group plc was incorporated in May 2015 with the purpose of gathering successful marketing businesses under one roof. The Company comprises a series of independent marketing teams, each with specific expertise and innovative services. The consolidated group supports the subsidiaries with management and coordinating activities as well as a common operating platform. For more information, please visit the Company’s website www.marketinggroupplc.com. The Company’s share is listed on Nasdaq First North Stockholm from 8 June 2016 and Mangold Fondkommission AB, +46 8-5030 15 50, is the Company’s Certified Adviser and liquidity provider. ENDS 

Evolution to launch Hippodrome’s own Live Casino and ‘Live from The Hippodrome’ feed

The Hippodrome’s own Live Casino service will be built around Evolution’s generic live tables, located at Evolution’s Riga studios, and a Dual Play Roulette table to be sited within Lola’s, The Hippodrome’s underground casino. The Evolution Dual Play Roulette table on the gaming floor in Lola’s will allow online players on desktop, tablet and smartphone to play with players seated at the same Lola’s table. This dual play (or ‘convergence’) capability is enabled by an Evolution state-of-the-art Live Casino camera and sound studio installation around the actual table. As well as being a focal point of The Hippodrome’s own Live Casino service, the Lola’s Dual Play Roulette table will be made available as a ‘Live from the Hippodrome’ feed to Evolution’s other licensees. This will allow any Evolution licensee’s players to sample the unique atmosphere of Lola’s, which recreates the under-stage Hippodrome live entertainment club of 1900. George Constantinou, Director of Online Operations at The Hippodrome Casino, said: “The Hippodrome is a powerful and highly recognisable brand in the gaming and entertainment world. This exciting initiative with Evolution will enable players to play not only at our historic destination casino, but to actually play online at a real table set amidst the unique and pulsating atmosphere of Lola’s.” Jens on Bahr, CEO and co-founder at Evolution Gaming, commented: “This is another major step in our land-based and convergence strategy — a step that will both enrich the gaming experience for online players and expand the services available to all Evolution licensees. Existing and new Hippodrome and Lola’s patrons will be able to experience the thrill of playing at this historic venue’s tables from virtually any location, even when they are not able to visit the venue in-person.”

HALF-YEARLY REPORT JANUARY – JUNE 2016

Comments from CEO Fredrik Olsson  The second quarter showed continued strong sales growth for the Company’s products and was the single best quarter in the history of the Company. Sales amounted to SEK 4.6 million, an increase of 30 percent year over year and 21 percent quarter over quarter. For the six-month period as a whole sales rose 31 percent, demonstrating stable organic growth in the product portfolio. It is particularly gratifying that we see growth in all product groups during the period. At the end of the second quarter, we reached a settlement in the legal dispute that has been ongoing since 2014. We are pleased to have reached an agreement that gives us royalty income at good levels, but above all, the agreement is strategically important to increase the size of the market and to improve conditions for faster adoption of FabRICATOR in the production of antibody drugs. Now that there are two suppliers of the enzyme, the prospects have improved for the enzyme to be included in critical methods of analysis for the production of antibody-based drugs. The market for antibody-based drugs is undergoing strong growth and there is a clear need to simplify and improve the analytical methods associated with production. We are now also seeing more requests for larger volumes for use specifically in quality control in the production of antibodies, for which reason I expect continued growth for FabRICATOR since we are still in an early stage. While revenues from sales have increased sharply, the cost base--excluding the legal costs of the dispute with Promega--has declined 13 percent compared with the first half of 2015. However, the legal expenses associated with the dispute have had a negative impact on earnings for the period. As a result of the settlement, these expenses will end during the beginning of the third quarter. It is worth noting that organic growth continues without any negative effect on gross margin, indicating efficient use of resources in the production of our products and that the price level remains at a satisfactory level. As I look ahead to the rest of the year I expect continued good organic growth. We will increase our efforts in sales and marketing to further drive growth. A clearer presence in the Asian markets will be prioritized, while strengthening our own sales organization in North America and Europe. We will also continue to work to broaden the market for our existing product portfolio with new products aimed at new applications, at the same time that we follow the strategy of expanding the product portfolio by introducing new products. In line with this strategy, in the second quarter we launched two new products – GingisREX and FabULOUS Fab Kit. GingisREX opens a new market for us because the product can not only be used for antibodies, but also within general protein analysis. FabULOUS Fab Kit simplifies handling of antibody fragments for a certain type of antibody during production. In May we carried out a rights issue that was oversubscribed. The additional capital, together with the strong growth we continue to demonstrate, will provide good conditions for further investments in market expansion and a continued positive trend for Genovis. I would like to thank all of our engaged shareholders and dedicated employees for their efforts, which have resulted in yet another successful six months and created good prospects for a positive development moving forward.

RECTIFICATION TO THE PRESS RELEASE “BLOCK TRADE IN THE MARKETING GROUP PLC” RELEASED THIS MORNING

In the press release ‘Block Trade In The Marketing Group plc’, the date of purchase of shares and the percentages were incorrectly stated. Chairman Jeremy Harbour and director Callum Laing acquired the shares on August 29, 2016. Jeremy’s holdings now amounts to 17.05 per cent and Callum’s holdings amounts to 8.18 per cent. Below the revised press release. Stockholm, August 29, 2016 – On August 29, 2016, chairman Jeremy Harbour acquired 170,016 ordinary shares and director Callum Laing acquired 170,015 ordinary shares in The Marketing Group in a block trade with an agreed price per share of 6.47 Euros. After the transaction, Jeremy’s holdings in The Marketing Group including direct and indirect as well as through entities he either has a shareholding in or discharges managerial responsibilities amounts to 17.05 per cent and Callum’s holding in The Marketing Group including direct and indirect as well as through entities he either has a shareholding in or discharges managerial responsibilities amounts to 8.18 per cent. For more information, please contact Hannah Middleton, Director and Communications DirectorPhone: +65 8193 7625E-mail: hannah.middleton@marketinggroupplc.com Jeremy Harbour, Executive ChairmanPhone: +65 8661 1776E-mail: jeremy.harbour@marketinggroupplc.com The Marketing Group in brief The Marketing Group plc was incorporated in May 2015 with the purpose of gathering successful marketing businesses under one roof. The Company comprises a series of independent marketing teams, each with specific expertise and innovative services. The consolidated group supports the subsidiaries with management and coordinating activities as well as a common operating platform. For more information, please visit the Company’s website www.marketinggroupplc.com. The Company’s share is listed on Nasdaq First North Stockholm from 8 June 2016 and Mangold Fondkommission AB, +46 8-5030 15 50, is the Company’s Certified Adviser and liquidity provider. ENDS 

Alfa Laval presents first results from strategic review

The strategic directionAlfa Laval has enjoyed an overall strong development for a long period of time thanks to solid market positions and a successful M&A program. During recent years the organic growth has, however, been below expectations. The strategic review focuses on getting the company back on a solid growth path and to manage the short-term challenges caused by the weaknesses in the oil & gas and marine sectors. "The new strategic direction will put us in a better position to identify and capture organic growth opportunities,” says Tom Erixon, President and CEO of the Alfa Laval Group. “It will also increase competiveness and build the strength necessary to succeed in a slow market”. The new strategic direction rests on three pillars: customers, products and services. · Improve customer interaction - the purchasing process must be as convenient and responsive as possible for customers. To make this happen, a new organization structure will be formed, with the main objective to create speed in the customer interaction through clarity and accountability. Another important element is being more selective in terms of market and application presence. Alfa Laval’s resources can then be dedicated in a more efficient way – targeting fewer areas with clear growth opportunities.  · Build on our technological strengths – the three key technologies and core products groups continue to be the backbone of Alfa Laval. The new strategy will for instance put increased focus on supporting customers to achieve improved energy efficiency and environmental performance. Another area involves further exploring the opportunities associated with digitalization, in order to deliver additional value to customers.It also includes important measures to strengthen R&D, such as the decision to invest in a new development laboratory for high-speed separators in Sweden. Together with other measures, the development time for the next generation separators will be significantly reduced and performance in the development process will be improved.   · Further grow the service offering – service is an integral part of Alfa Laval’s offering and of high importance to most customers. The company will continue to develop its service culture, offering, and presence. Examples of recent decisions to expand the service capability include the opening of new service centers in Iran, Angola and California, USA. They will all open during 2016. An organization to support the strategic directionIn order to drive the development and deliver results a new organization will be launched January 1, 2017. It will be based on three industry-oriented business divisions; the Marine division, the Food & Water division and the Energy division. The divisions will consist of product-based business units. Operations will remain a common supply chain, but with closer ties to the business unit structure. The three regional sales functions will be consolidated into one Global Sales & Service organization. “Forming the Marine division back in 2011 was a successful move. Now we follow up with a Food & Water division and an Energy division”, says Tom Erixon. The new structure will result in a smaller Group Management, going to 9 from 11 members. Three group management members retire; Ray Field - Asia, Göran Mathiasson - Operations and Svante Karlsson - Process Technology. Mikael Tydén will replace Göran Mathiasson as head of Operations. Several of the remaining members of group management will get new roles. (The new group structure as well as well as photos can be found at http://www.alfalaval.com/investors as related material to the news release.) The new strategic direction is a long-term commitment which will also include short-term initiatives addressing the need to adapt to prevailing market conditions. More detailed information about the different initiatives will be released gradually. Complete information about the strategic review is expected to have been given latest in conjunction with the Alfa Laval Capital Markets Day, November 22, 2016.   “Alfa Laval has always supported its customers in a consistent way, delivering solutions that make their operations more efficient and more sustainable,” says Tom Erixon. “Going forward, the customers will find it even easier to do business with us and our employees will recognize that Alfa Laval is an exciting place to be.” Alfa Laval will host a telephone conference on August 30 at 09:30 a.m CETTo join the telephone conference – hosted by Alfa Laval’s President and CEO Tom Erixon, and Thomas Thuresson, CFO – sign up via the link below. Once registered, you will receive a phone number, a participant pin and a conference pin. Please dial in 10 minutes prior to the schedule start of the event. If you are having difficulties registering, contact Intercall at +44 20 8288 5566.  https://eventreg2.conferencing.com/webportal3/reg.html?Acc=027199&Conf=222510  You can also follow the conference via a live webcast. A webcast link will be available on www.alfalaval.com/investors.   If you want to listen to the replay, call +44 (0)20 7031 4064 or +46 (0)8 5052 0333, conference code 95 99 03. The recording will be available for 24 hours. After that, you can go to www.alfalaval.com/investors and watch and listen to an on-demand version of the webcast. About Alfa Laval                                                                                                                                          Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling. The company’s equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol. Alfa Laval’s products are also used in power plants, aboard ships, oil and gas exploration, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications. Alfa Laval’s worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena. Alfa Laval is listed on Nasdaq OMX, and, in 2015, posted annual sales of about SEK 39.7 billion (approx. 4.25 billion Euros). The company has about 17 500 employees. www.alfalaval.com  For more information, please contact: Peter TorstenssonSenior Vice President, CommunicationsAlfa LavalTel: + 46 46 36 72 31Thomas ThuressonCFOAlfa LavalTel: +46 46 36 72 40 This information is information that Alfa Laval AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at CET 08:30 on August 30, 2016.

Brian Hodges is awarded the Karolinska Institutet Prize for Research in Medical Education

Professor Hodges, Professor at the Faculty of Medicine and Ontario Institute for Studies in Education at the University of Toronto, Canada, will receive the award and a prize amount of €50,000 at a ceremony in Stockholm, Sweden, on 13 October.This international prize is awarded for outstanding research in medical education. The purpose of the prize is to recognise and stimulate high-quality research in the field and to promote long-term improvements of educational practices in medical training. "Medical" includes all education and training for any health science profession. The prize is made possible through financial support from the Gunnar Höglund and Anna-Stina Malmborg Foundation. It is currently awarded every second year.“This year’s prize winner was an easy choice, as Professor Hodges’ research is of such outstanding significance, quality and originality. It has led to changes in practice and has had an impact on medical education. Professor Hodges has embraced both quantitative and best-practice qualitative methodologies. The outcomes of the research are well recognised as a substantial contribution to the medical education literature,” says Professor Sari Ponzer, Chair of the Prize Committee.Professor Hodges has since the early 1990s advocated a closer examination of the role that medical education plays in society. His research focuses on the nature of competence, how it has been constructed in different historical periods, across different countries and cultures, and how it is assessed using a range of assessment tools and systems. He has successfully advocated including simulations and assessment of mental health and communication skills in examinations for medical students and residents and for other health professionals. This is now standard practice in his native Canada and many other countries.“When I was in medical school, all exams were written or oral; there were few simulations as part of the examination process. Today, the use of simulated patients is widespread internationally, and has changed the way that medical students are assessed. In a perfect world, health professionals would go back every year of their career to engage in challenging simulations to test their clinical and communication skills. That’s what I’m currently working on,” says Professor Hodges.“Our research team was the first in the world to experiment with the validity of complex communication and mental health simulations. I’m proud that these types of simulations are now part of the medical examination process, in combination with physical assessment. This is important, as we often need to deal with patients or family members who are anxious or emotionally distressed in a hospital environment. It is important to have the chance to practice in a safe environment before, for example, dealing with relatives of a dying patient or a patient who is angry or confused. I’m glad there is more focus on these types of teaching and assessment these days.”Professor Hodges continues: “Communication is key for health professionals, both between patient/physician and between colleagues in the medical community. Caring and compassion are the foundation of our profession. I would also like to see a more team-based approach, as medicine is all about teamwork for safer practice. Team-based simulations should be part of all medical environments in the same way as other sectors including airlines, nuclear power and others where it’s essential to work together in unison, train together to help minimise risks.”Commenting on his Prize win, Professor Hodges says:”I was really quite taken aback when I received the call from the Committee. It’s a wonderful honour to be recognised for this prominent prize. As I have a strong belief in philanthropy, I will donate most of the prize money to continue to further support research in the medical education field.”Press image by photographer Alex DeOliveira is attached. More information about the Prize and the Prize recipient, view the attached pdf.  For any further queries, please contact:Professor Sari PonzerChair of the Prize CommitteeKarolinska Institutet Prize for Research in Medical EducationTel: +46 (0)8 616 23 46 or +46 (0)73 973 26 89Email: sari.ponzer@ki.se Associate Professor Italo MasielloScientific Secretary of the Prize CommitteeKarolinska Institutet Prize for Research in Medical EducationTel: +46 (0)76 052 80 27Email: italo.masiello@ki.se Karolinska Institutet press officeTel: +46 (0)8 524 860 77Email: pressinfo@ki.se

NeuroVive announces that the clinical study CiPRICS will be presented at the Swedish Thorax meeting in October 2016

Ass Prof. Henrik Bjursten M.D. Ph.D., Dept. of Cardiothoracic Surgery, Anesthesia and Intensive Care at Skåne University Hospital in Lund, will give an oral presentation with the title ”Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS). A Double Blind, Randomised, Placebo Controlled, Proof of Concept Study” at the Swedish Thorax meeting in Malmö on October 13, 2016. For further information about the program, please the conference web site: http://www.malmokongressbyra.se/svenska_thoraxmotet/program About CiPRICS The CiPRICS study (Ciclosporin to Protect Renal Function In Cardiac Surgery) is a double-blind, randomized and placebo-controlled explorative Phase II study that investigates NeuroVive’s drug candidate CicloMulsion as treatment for acute kidney injury (AKI). The patients are being treated with CicloMulsion or placebo in connection with coronary artery bypass surgery (CABG) at the Department of Cardiothoracic Surgery at Skåne University Hospital in Lund, Sweden. The study is investigator-initiated and performed by Skåne University Hospital with support from NeuroVive. More information about the study is published in the public database ClinicalTrials.gov. About NeuroVive NeuroVive Pharmaceutical AB (publ) is a pioneer in mitochondrial medicine and a company committed to the discovery and development of highly targeted candidates that preserve mitochondrial integrity and function in areas of significant therapeutic need. NeuroVive's business approach is driven by value-adding partnerships with mitochondrial research institutions and commercial partners across the globe. NeuroVive's portfolio consists of two clinical projects, one in acute kidney injury (CicloMulsion®) and one in traumatic brain injury (NeuroSTAT®). The candidate drug NeuroSTAT has orphan drug designation in Europe and in the US for treatment of moderate to severe traumatic brain injury and is currently being evaluated in the CHIC study. CicloMulsion is being evaluated in an on-going study, CiPRICS, in acute kidney injury during major surgery. Furthermore, the R&D portfolio consists of two late stage discovery programs and one compound in preclinical development. NeuroVive is listed on Nasdaq Stockholm, Sweden, Small Cap, under the ticker symbol NVP. The share is also traded on the OTC Markets Group Inc market in the US. NeuroVive Pharmaceutical (OTC: NEVPF) trades on the OTCQX Best Market. For investor relations and media questions, please contact:  Cecilia Hofvander, NeuroVive, Tel: +46 (0)46 275 62 21 or ir@neurovive.com  NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard) www.neurovive.com   This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 11:30 a.m. CEST on August 30, 2016.